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Abstract 
Infections by pathogenic marine bacteria are a major problem for both the 
shellfish and finfish aquaculture industries, causing severe disease and high mortality, 
which seriously affect aquaculture production and cause significant economic loss. 
Marine pathogens like Vibrio tubiashii and Roseovarius crassostreae frequently cause 
disease in a variety of shellfish. With the understanding that the use of antibiotics in 
large-scale aquaculture leads to the development and transfer of antibiotic resistance, 
investigation of probiotic approaches for the prevention of infectious disease has 
become important. In manuscript I, screening of bacterial isolates from Rhode Island 
marine organisms and environment using agar-based assay methods for detection of 
antimicrobial activity against oyster pathogens led to the isolation of candidate 
probiotic bacteria Phaeobacter gallaeciensis S4. P. gallaeciensis S4 is a 
gram-negative -Proteobacteria within the Roseobacter clade. Pretreatment of larval 
and juvenile oysters for 24 h with 104 CFU / mL of P. gallaeciensis S4 protected 
larval oysters against mortality resulting from challenge with R. crassostreae and V. 
tubiashii. Probiotic isolates had no negative impact on oyster survival. These results 
suggest the potential of marine bacterial isolate P. gallaeciensis S4 to serve as 
probiotic bacterium to control the infection and disease by bacterial pathogens in the 
culture of Crassostrea virginica. 
The probiotic bacterium P. gallaeciensis S4, isolated from the inner shell surface 
of a healthy oyster, secretes the antibiotic tropodithietic acid (TDA), is an excellent 
biofilm former, and increases oyster larvae survival when challenged with bacterial 
pathogens. In manuscript II, we investigated the specific roles of TDA secretion and 
biofilm formation in the probiotic activity of S4Sm (a spontaneous 
streptomycin-resistant mutant of the parental S4). For this purpose, mutations in clpX 
(ATP-dependent ATPase) and exoP (an exopolysaccharide biosynthesis gene) were 
created by insertional mutagenesis using homologous recombination. Mutation of clpX 
resulted in the loss of TDA production, no decline in biofilm formation, and loss of the 
ability of S4Sm to inhibit the growth of Vibrio tubiashii and Vibrio anguillarum in 
vitro. Mutation of exoP resulted in a ~70% decline in biofilm formation, no decline in 
TDA production, and delayed inhibitory activity towards Vibrio pathogens in vitro. 
Both clpX and exoP mutants exhibited reduced ability to protect oyster larvae from 
death when challenged by Vibrio tubiashii. Complementation of the clpX and exoP 
mutations restored the wild type phenotypes. We also found that pre-colonization by 
S4Sm was critical for this bacterium to inhibit pathogen colonization and growth. Our 
observations suggest that probiotic activity by S4Sm involves contributions from both 
biofilm formation and the production of the antibiotic TDA. 
In manuscript III, we found that culture supernatant of S4Sm down-regulates 
protease activity in V. tubiashii cultures. The effects of S4Sm culture supernatant on 
the transcription of several genes involved in protease activity, including vtpA, vtpB, 
and vtpR (encoding metalloproteases A and B and their transcriptional regulator, 
respectively), were examined by qRT-PCR. Expression of vtpB and vtpR were reduced 
to 35.9% and 6.6%, respectively, compared to an untreated control. In contrast, 
expression of vtpA was not affected. A V. tubiashii GFP-reporter strain was 
constructed to detect the inhibitory compounds. Three molecules responsible for V. 
tubiashii protease inhibition activity were isolated from S4Sm supernatant and 
identified as N-acyl homoserine lactones (AHLs): 
N-(3-hydroxydecanoyl)-L-homoserine lactone, 
N-(dodecanoyl-2,5-diene)-L-homoserine lactone and 
N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone, and their half maximal 
(50%) inhibitory concentrations (IC) against V. tubiashii protease activity are 0.264 
μM, 3.713 μM and 2.882 μM, respectively. Our qRT-PCR data demonstrated that 
exposure to the individual AHL reduced transcription of vtpR and vtpB, but not vtpA. 
Treatment with a combination of three AHLs (any two AHLs or all three AHLs) on V. 
tubiashii showed that there were additive effects among these three AHL molecules 
upon protease inhibition activity. These AHL compounds may act by disrupting the 
quorum-sensing pathway that activates protease transcription of V. tubiashii. 
v 
ACKNOWLEDGEMENTS 
Foremost, I would like to express my sincerest gratitude to my advisor Dr. David 
R. Nelson for the continuous support of my Ph.D. study and research, for his patience, 
motivation, enthusiasm, and immense knowledge. His guidance helped me in all the 
time of research and writing of this thesis. Also, I have been so lucky to have a 
supervisor who gave me the freedom to design and carry out my own experiments and 
learn from my mistakes. I thank him for not only for mentoring for my research work, 
but also caring about my career development. We had so many discussions over the 
years, both personal and scientific, to open my mind on science and life.  
I would like to thank the members of my defense committee and comprehensive 
exam committee: Dr. Paul Cohen, Dr. David Rowley, Dr. Marta Gomez-Chiarri and 
Dr. Kerry L. Laplante for their guidance, suggestions, and understanding. I especially 
thank Dr. Cohen for his valuable advice regarding my research and career choice.  
I thank the faculty and staff of the Department of Cell and Molecular Biology. It 
was an honor and a privilege to work with and learn from all of you. I would 
especially like to thank Dr. Gongqin Sun and Baohong Zhang for their help and 
solicitude during my entire Ph.D. study in URI. I would also like to thank Paul 
Johnson, manager of the URI Genomics and Sequencing Center, and Janet Atoyan for 
their expertise and training on equipment used in this study. 
vi 
I would like to thank all the members of the Nelson lab that I had such a pleasure 
to work with during my time at URI. I thank Dr. Xiangyu Mou for teaching me a lot of 
technologies when I just started to work in the lab. I especially thank Ken Gareau, 
Michael Pereira, Alla Peselis, Edward Spinard, Linda Kessner and Anthony Carlone 
for their valued friendship, as well as their countless discussion and advice regarding 
this project. 
I would like to thank all other members in the Probiotic team, Dr. Murni Karim, 
Sae Bom Sohn, Christine Dao, and Dr. Tao Yuan. It was such a great time to work 
with all of you. I thank them for contributing their time and talent for this work. I 
know without anyone of this team this work cannot be done. 
Finally, I thank my family and friends for their support during my pursue Ph.D. 
degree. I thank my father Shirui Zhao, my mother Shuqin Wang, my sister Wenjuan 
Zhao, and my husband Dr. Xiangyu Mou for their unconditional love and support: this 
body of work is dedicated to you. I cannot thank you enough for your love, 
encouragement, patience and understanding during this process. 
vii 
PREFACE 
This dissertation has been prepared in the Manuscript Format according to the 
guidelines of the Graduate School of the University of Rhode Island. The dissertation 
includes an introduction and the following three manuscripts: 
The first manuscript: “Probiotic Strains for Shellfish Aquaculture: Protection of 
Eastern Oyster, Crassostrea virginica, Larvae and Juveniles Against Bacterial 
Challenge” was published in Journal of Shellfish Research in 2013.  
The second manuscript: “Contributions of tropodithietic acid and biofilm 
formation to the probiotic activity of Phaeobacter gallaeciensis” will be resubmitted 
to PLOS ONE.  
The third manuscript: “The probiotic bacterium, Phaeobacter gallaeciensis S4, 
down-regulates protease virulence factor transcription in the shellfish pathogen, Vibrio 
tubiashii, by quorum quenching” has been written in the same form as the second 
manuscript and will be submitted for publication. 
viii 
TABLE OF CONTENTS 
CONTENT               PAGE 
ABSTRACT……………………………………………………………… ii 
ACKNOWLEDGEMENTS……………………………………………… v 
PREFACE………………………………………………………………… vii 
TABLE OF CONTENTS………………………………………………… viii 
LIST OF TABLES……………………………………………………….  ix 
LIST OF FIGURES……………………………………………………… xi 
LITERATURE REVIEW………………………………………………... 1 
MANUSCRIPT I ………………………………………………………… 28 
MANUSCRIPT II………………………………………………………… 64 
MANUSCRIPT III………………………………………………………. 119 
ix 
LIST OF TABLES 
TABLES                   PAGE 
LITERATURE REVIEW 
Table 1. General genomic features of Phaeobacter gallaeciensis strains……............20 
Table 2. Comparison of catabolic pathway activity and origins of metabolic 
intermediates in central carbon metabolism of D. shibae, P. gallaeciensis and other 
bacteria derived from carbon labeling experiments ……………............................…21 
MANUSCRIPT I 
Table 1. Antibiotic activity of candidate probionts Phaeobacter sp. S4 and Bacillus 
pumilus RI06-95 against selected bacterial pathogens of finfish (Vibrio harveyi BB120) 
and shellfish (V. tubiashii RE22 and Roseovarius crassostreae CV919-312T) as 
determined by 2 plate diffusion assays at 2 temperatures.…………................. ……..50 
Table 2. Effect of preincubation with candidate probionts Bacillus pumilus RI06-96, 
Phaeobacter sp. S4, and commercial probiotic mix Sanolife MIC (INVE Aquaculture, 
Belgium) on larval oyster survival 24 h after challenge with bacterial pathogens 
Roseovarious crassostreae CV919-312T and Vibrio tubiashii RE22.……….......…...51 
MANUSCRIPT II 
Table 1. Bacterial strains and plasmids used in this study.….................................…..94 
Table 2. Primers used in this study ……….............................................…….........…96 
Table 3. Quantification of biofilm formationby measuring OD580 of crystal violet dye 
attached to the cells forming biofilms on glass tubes at 27C under static condition at 
60 h…......................................................................................................................…..97 
x 
Table 4. Killing ability of culture supernatant of various P. gallaeciensis strains 
against V. anguillarum NB10Sm cell. …….......................................................……..98  
Table S1. Bacterial Generation time of Phaeobacter gallaeciensis (S4Sm), Vibrio 
anguillarum (NB10Sm), and Vibrio tubiashii (RE22Sm) strains growing in YP30 
during mid-log phase …......................................................………………………...111 
Table S2. Competition assay between Phaeobacter strains and V. tubiashii (RE22Sm) 
with pre-colonization of Phaeobacter .……............................................. …………112 
MANUSCRIPT III 
Table 1. Bacterial strains and plasmids used in this study……………...........……...145 
Table 2. Primers used in this study ………...............…….…………..……....……..146 
Table S1. AHLs secreted by various bacterial strains detected using AHL indicator 
strains…......................................................................................................................165 
  
 
 
 
 
 
 
 
 
 
 
xi 
 
LIST OF FIGURES 
FIGURES                   PAGE 
LITERATURE REVIEW 
Figure 1. Metabolic network of the central carbon metabolism of Dinoroseobacter 
shibae and Phaeobacter gallaeciensis as predicted from the annotated genome 
sequence .......................................................................................................................22 
Figure 2. Degradation of DMSP via (A) demethylation and (B) cleavage pathways...24 
Figure 3. Proposed model for the biosynthesis of TDA in P. gallaeciensis DSM 
17395….........................................................................................................................26 
MANUSCRIPT I 
Figure 1. Effect of preincubation with candidate probiont Phaeobacter sp. S4 on the 
morphology of larval oysters 24 h after challenge with the bacterial pathogen Vibrio 
tubiashii RE22…...........................................................................................................52 
Figure 2. Growth curve of Phaeobacter sp. S4 in YP2 and YP3 at 27C……............54 
Figure 3. Phase contrast micrographs showing the morphology of Phaeobacter sp. S4 
in different growth phases…….........................................................………..………. 56 
Figure 4. Effect of preincubation of larval oysters with candidate probionts RI06-95 
and S4 at 104 CFU ml-1 on survival (%± SEM) 24 h after challenge with bacterial 
pathogens Roseovarious crassostreae CV919-312T and Vibrio tubiashii RE22 at 105 
CFU ml-1 .……………...............................................................................…….…….58 
Figure 5. Length of protection to bacterial challenge provided by preincubation of 
larval oysters with candidate probionts RI06-95 and S4…………....................……..60 
xii 
Figure 6. Effect of preincubation of juvenile oysters with candidate probionts on 
oyster survival after bacterial challenge……..........................................……………..62 
MANUSCRIPT II 
Figure 1. A and B) Reversed-phase HPLC chromatograms of ethyl acetate extracts 
from Phaeobacter strains showing presence (A) or absence of TDA (B). C) Inhibition 
zone assay of S4Sm, clpX mutant (clpX), clpX complement (clpX+), exoP mutant 
(exoP) or exoP complement (exoP+) on YP30 plates coated by V. anguillarum 
(NB10Sm), V. tubiashii (RE22Sm) or Roseovarius crassostreae (CV919Sm) after 24 h 
at 27C…………..............................................................………………..…………. 99 
Figure 2. Competition assay between P. gallaeciensis strains and V. tubiashii with 
pre-colonization of glass surfaces by P. gallaeciensis for 24h. ….................……….101 
Figure 3. TDA supplementation in co-culture system between clpX mutant and V. 
tubiashii.......................................................................................................................103 
Figure 4. Effects of V. tubiashii on the growth of P. gallaeciensis strains in a 
competition assay with a 24 h pre-colonization by P. gallaeciensis.…….......……...105 
Figure 5. Competition assay between Phaeobacter strains and V. tubiashii without 
pre-colonization by Phaeobacter…................................................................………107 
Figure 6. Effect of pre-incubation of larval oysters with P. gallaeciensis strains at 104 
CFU/ml on survival (%± SE) 24 h after challenge with bacterial pathogen Vibrio 
tubiashii RE22 at 105 CFU/ml…………….............................……………………...109 
Figure S1. A) Reversed-phase HPLC chromatograms of ethyl acetate extracts from 
Phaeobacter mutant strains. B) Quantification of biofilm formation by measuring 
xiii 
OD580 of crystal violet dye attached to the cells forming biofilms on glass tubes at 
27C under static condition.…….........................................................................…...113 
Figure S2. Competition assay between Phaeobacter strains and V. anguillarum 
(NB10Sm) without pre-colonization of Phaeobacter………..........................….......115 
Figure S3. Effects of V. anguillarum NB10 on the growth of P. gallaeciensis strains in 
a competition assay with a 24 h without pre-colonization by P. gallaeciensis...........116 
MANUSCRIPT III 
Figure 1. Effects of supernatant of P. gallaeciensis S4Sm upon protease activity and 
growth of V. tubiashii RE22Sm………….........................................…………..……147 
Figure 2. Effects of supernatant of P. gallaeciensis S4Sm upon transcription of vtpA, 
vtpB and vtpR in V. tubiashii RE22Sm…………........................................…………149 
Figure 3. Effects of different fractions of P. gallaeciensis S4Sm supernatant upon 
protease activity and growth of V. tubiashii RE22Sm….………................................151 
Figure 4. Schematic diagram of isolation process of three N-acyl homoserine 
lactones .......................................................................................................................153 
Figure 5. Chemical structures of three N-acyl homoserine lactones ….....................155 
Figure 6. Concentration–response analyses of the three AHLs……......................…157 
Figure 7. Effects of single AHL treatment upon transcription of vtpA, vtpB, and vtpR in 
V. tubiashii RE22Sm…….…..................................................………………………159 
Figure 8. Effects of different combinations of three AHLs upon protease activity of V. 
tubiashii RE22Sm………...........................................................................................161 
Figure 9. Proposed model: inhibition mechanism of P. gallaeciensis AHLs…......…163 
xiv 
Figure S1. Effects of P. gallaeciensis supernatant upon protease activity of V. tubiashii 
supernatant. …………........................................................……………....…………166 
Figure S2. Effects of TDA at different concentration (0.5 μg/ml or 1.0 μg/ml) upon 
protease activity and growth of V. tubiashii RE22Sm……................................……168 
Figure S3. Effects of P. gallaeciensis AHLs upon growth of V. tubiashii 
RE22Sm…..................................................................................................................170 
Figure S4. Effects of supernatant of P. gallaeciensis S4Sm upon transcription of vanT 
in V. anguillarum m93Sm….………..................................................................…....172 
Figure S5. Effects of supernatant of V. tubiashii RE22Sm upon growth and 
transcription of raiR in P. gallaeciensis S4Sm……......................................…..…...174 
Appendix A (additional table for Manuscript I) ........................................................176 
Appendix B (additional figures for Manuscript III) ...................................................177 
 
 
 1 
 
 
LITERATURE REVIEW 
Overview of Phaeobacter gallaeciensis 
 2 
Abstract 
Phaeobacter gallaeciensis, a member of the gram-negative -Proteobacteria, 
belongs to the Roseobacter clade. The Roseobacter clade, an important member of 
the marine microbiota, accounts for as much as ~40% of prokaryotic DNA from 
the ocean and plays an important role in the organic sulfur cycle of the ocean. P. 
gallaeciensis exhibits a diverse ecological distribution and is found to be both 
free-living and host-associated. This indicates that P. gallaeciensis is metabolically 
versatile, able to survive and thrive in a variety of environments. Also these traits 
can be supported by their genome sequences. Analysis of completed genomes 
indicated the ability to produce various secondary metabolites. P. gallaeciensis is 
able to secrete tropodithietic acid (TDA), a broad spectrum antibiotic. In addition 
to antibiotics, P. gallaeciensis also produce N-acyl homoserine lactones, which are 
commonly used by Gram-negative bacteria for quorum sensing. Moreover, genes 
encoding for roseobacticides and siderophore can also be found in P. gallaeciensis 
genomes. Comparison of P. gallaeciensis genomes with other Roseobacter strains 
revealed unique or characteristic features for P. gallaeciensis. P. gallaeciensis has 
been demonstrated to exhibit probiotic activity with many marine host species, and 
TDA plays an important role in probiotic activity of P. gallaeciensis.    
 3 
Introduction 
Members of the genus Phaeobacter are gram-negative -Proteobacteria, and 
belong to the Roseobacter clade. The Roseobacter clade, an important member of 
the marine microbiota, accounts for as much as ~40% of prokaryotic DNA from 
the ocean and plays an important role in the organic sulfur cycle of the ocean [1-3]. 
Although Phaeobacter is exclusively isolated from marine or hypersaline 
environments [4], it has a diverse and broad ecological distribution, from coastal 
environments to fish farms [5]. Phaeobacter are found to be free-living, particle 
associated (with microalgae and rotifers [6]), or in commensal relationship with 
marine phytoplankton, invertebrates (cephalopods [7]) and vertebrates (turbot larva 
[8] and seahorses [9]). Several species from Roseobacter clade, Phaeobacter 
gallaeciensis, Phaeobacter inhibens and Ruegeria mobilis, have been shown to 
exhibit inhibitory activity against marine pathogens and protect fish larvae from 
infections by these pathogenic bacteria [10]. 
Roseobacter gallaeciensis was first reported in 1998 [11], and reclassified as 
the type species of a new genus, Phaeobacter, as Phaeobacter gallaeciensis in 
2006 [12]. P. gallaeciensis strains are generally isolated from alga or larval 
cultures of marine fish [10]. It is a short rod with 1-2 flagella on one or both poles 
[10,13,14]. It can form rosettes, is an excellent biofilm former, and a dominant 
colonizer of surfaces in marine environments [13,14]. P. gallaeciensis has been 
used as a probiotic treatment to reduce the density of the fish pathogen Vibrio 
anguillarum, resulting in the prevention of vibriosis in the cod [6] or turbot larvae 
[15]. Due to its ecological and aquaculture importance, this review will focus on 
the current research progress about P. gallaeciensis, including knowledge about 
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genomes, metabolism, secondary metabolite secretions and potential probiotic 
mechanisms.  
Main body 
1. Genomes of P. gallaeciensis  
To date, only three P. gallaeciensis completed genomes are available, and 
they are P. gallaeciensis strains 2.10 [16], DSM 17395 [16] and DSM 26640 [17]. 
Additionally, two draft genomes from P. gallaeciensis strains ANG1 [18] and 
BS107 [16] are available. Comparison of those three completed genomes revealed 
that strains 2.10 and DSM 17395 share more similarities with each other than with 
DSM 26640. The genomes of 2.10 and DSM 17395 are 4.16 Mb and 4.23 Mb (< 
2% difference in size), respectively, and each is composed of a single circular 
chromosome and three plasmids. On the nucleotide level, the genomes differ by 
only 3% and the chromosome and plasmids extensive synteny. Strain 2.10 has 
3798 ORFs, and DSM 17395 harbors 3960 ORFs; they share a total of 3438 
coding sequences (or ~87-91% of their ORFs, respectively). The DSM26640 
genome is 7-9% larger at 4.54 Mb. It is organized into a single circular 
chromosome and seven plasmids, which has 4437 ORFs (Table 1). Comparison 
with other Roseobacter genomes revealed genomic traits that are characteristic for 
P. gallaeciensis strains. The two finished P. gallaeciensis genomes (2.10 and DSM 
17395) possess 74 orthologous genes that are not present in other Roseobacter 
bacteria [16]. Most of these genes show no functional annotations; however, two 
sets of genes with functions can be potentially used as unique chemotaxonomic 
markers for this species. The two sets of genes are two copies of a chromosomally 
encoded D-alanine poly-ligase (dltA) and a cluster of genes for biosynthesis and 
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transport of siderophore. The dltA gene is involved in biosynthesis of lipoteichoic 
acid, which is a constituent of the Gram-positive bacteria cell wall in many 
organisms. This suggests that P. gallaeciensis may have an uncommon cell 
envelope composition or that the annotation is not correct. A second feature is the 
presence of a cluster of genes involved with siderophore synthesis. This suggests 
that P. gallaeciensis may use the siderophore to facilitate iron uptake from 
environment, perhaps allowing it to outcompete pathogenic bacteria [16]. The 
differences between P. gallaeciensis genomes with other members of the 
Roseobacter clade suggest P. gallaeciensis potential to adapt to a variety of marine 
environments and also allows it to associate with a wide variety of hosts.     
2. Metabolism of P. gallaeciensis 
P. gallaeciensis is strictly aerobic heterotrophic [19-21] and metabolically 
versatile [16,21], which could contribute to its wide ecological distribution. Here 
features of the central carbon and sulfur metabolisms in P. gallaeciensis will be 
reviewed. 
2.1. Central carbon metabolism in P. gallaeciensis 
2.1.1. Pathways for glucose catabolism 
The carbon core metabolism of P. gallaeciensis possesses three 
potential routes for glucose catabolism, as predicted from the annotated 
genome sequence. Glucose can be alternatively catabolized through 
glycolysis (EMP), the Entner-Doudoroff pathway (EDP) and the pentose 
phosphate pathway (PPP) [19]. By using 13C labeled isotopes the metabolic 
fluxes in the central carbon metabolism of P. gallaeciensis was obtained 
(Fig. 1) [19]. The use of [1-13C] glucose by each different pathway yields to 
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a different labeling pattern in specific amino acids, which can be used as a 
differentiation marker of the flux. Interestingly, P. gallaeciensis mainly 
uses the ED pathway during growth on glucose. The quantification of 
different fluxes revealed that the use of the ED pathway amounts to >99%, 
whereas glycolysis and PPP pathways only contribute <1% (Table 2). Most 
organisms, such as E. coli [22] and B. subtilis [23], use glycolysis and PPP 
pathways, though at different ratios. This should result from lack of 
phosphofructokinase, which converts fructose-6-phosphate to fructose 
1,6-bisphosphate, in P. gallaeciensis. The exclusive utilization of ED 
pathway has been also observed in Pseudomonas and Arthrobacter for the 
same reason [24,25]. 
2.1.2. Anaplerotic reactions 
Oxaloacetate, as a central metabolite, can be formed by two major 
pathways, carboxylation involving pyruvate carboxylase or via pyruvate 
dehydrogenase and the TCA cycle. By using the same isotope-labeling 
method both pathways are demonstrated to be active in P. gallaeciensis 
[19].  
2.2. Sulfur metabolism in P. gallaeciensis 
Genome data from sequenced bacteria from the Roseobacter clade 
revealed that pathways for the degradation of sulfur metabolic pathways are 
widespread [26]. The main source of marine organic sulfur is 
dimethylsulfoniopropionate (DMSP), which is produced by a wide range of 
marine organisms and especially large amounts by dinoflagellates [27]. DMSP 
is generally degraded by marine bacteria via two competing pathways, one is 
 7 
lysis to volatile dimethyl sulfide (DMS), which in atmosphere is converted to 
condensation nuclei for water droplets, by a DMSP lyase; the other way is via 
demethylation to 3-(methylmercapto) propionic acid (MMPA), which may be 
transformed into methanethiol (MeSH) (Fig. 2) [28,29]. DMS and MeSH are 
important participants in the biogeochemical sulfur cycle [28,30]. DMSP in the 
ocean attracts Roseobacter bacteria, including P. gallaeciensis, which use it as 
carbon and sulfur source. Based on the genomic sequence, P. gallaeciensis 
possess genes involved in both DMSP degradation pathways, include a gene 
encoding the DMSP lyase DddP, which is encoded on its chromosome, and a 
dmd-gene cluster for the demethylation pathway located on a plasmid. Using 
deuterium labeled [2H6] DMSP and monitoring the derived volatile sulfur with 
the isotopic signal confirmed the prediction above based on the genomic 
sequence [29]. Degradation of DMSP by P. gallaeciensis contributes to sulfur 
cycling in the world’s oceans [29].   
3. Secondary metabolites 
Genome sequence analysis suggested that P. gallaeciensis strains are able 
to produce several interesting secondary metabolites. Tropodithietic acid, a 
broad-spectrum antibiotic, is able to inhibit many human or marine pathogens, 
especially Vibrio species [10,31]. TDA production has been demonstrated to 
play an important role in probiotic activity of P. gallaeciensis [6,32]. In 
addition, other secondary metabolites, like N-acyl homoserine lactones (AHLs), 
can be produced by P. gallaeciensis strains and several AHL synthases are 
found in their genomes [33]. It was shown that P. gallaeciensis BS107 strain 
genome harbors a hybrid polyketide synthase / non-ribosomal peptide 
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synthetase cluster, which potentially encode enzymes involved in the synthesis 
of various pharmaceutically important natural products [34]. It was also 
reported that BS107 is able to produce potent but selective algicides (named 
roseobacticides A and B, small molecules modulating the symbiosis 
relationship between algae and bacteria) upon sensing the lignin-derived 
breakdown product p-coumaric acid [35]. Moreover, several P. gallaeciensis 
strains encode a cluster for biosynthesis and transport of an iron-chelating 
siderophore, which is located on one of their plasmids [16]. Production of 
various secondary metabolites suggested diverse interaction between P. 
gallaeciensis and other marine species, and adaptation of the strains to different 
ecological niches. Several important secondary metabolites are selected to be 
reviewed here.  
3.1. TDA production in P. gallaeciensis 
3.1.1. TDA biosynthesis and regulation 
TDA is a sulfur-containing and broad-spectrum antibiotic with 
inhibitory activity towards a wide range of human- and marine-pathogens, 
including both gram-negative and gram-positive bacteria [2]. The TDA 
structure has been resolved [2]. A proposed model for biosynthesis of TDA 
in P. gallaeciensis DSM 17395 is presented in Figure 3, combining the 
results from several publications [16,36,37]. By using transposon insertion 
mutagenesis and screening for mutants with less yellow pigment from TDA, 
26 genes were identified to be essential for TDA synthesis (Fig. 3) [16]. 
These genes are located in a cluster on a plasmid, including the well-known 
key TDA production genes tdaABCEF [2], and the rest genes are scattered 
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over the chromosome and affiliated with different pathways of the primary 
metabolism.  
Several regulatory genes for TDA synthesis have also been identified, 
including tdaA [33], iorR [38], clpX [2] and pgaR [33]. TdaA was shown to 
be able to induce expression of tdaBEF in the same operon [33]. The iorR 
gene is located adjacent to gene ior1 and was shown to be important for the 
transcription of ior1 and phenylalanine catabolism [38]; ClpX is an AAA+ 
ATPase that functions as an unfoldase chaperon for ClpP (ATP-dependent 
protease) and with ClpP forms the multimeric ClpXP protease [39]. PgaR is 
part of PgaRI, a LuxRI-type quorum-sensing system, which up-regulate the 
transcription of tdaA. Mutations in pgaR or pgaI caused reduction of TDA 
production in P. gallaeciensis [33]. This indicated that QS is involved in 
regulation of TDA production. Interestingly, TDA may also function as an 
autoinducer, as addition of exogenous TDA into QS mutants increases the 
expression of TDA synthesis genes in P. gallaeciensis [33] and Silicibacter 
sp. TM1040 [40]. Cultivation conditions also influence TDA production. 
DSM 17395 produces 10-fold-higher amounts of TDA during shaken 
culture conditions than during static conditions [33]. The production of 
TDA is regulated by a complex regulatory network, which may act at 
different levels in a regulatory cascade. Such a complex regulatory network 
would be required by the need of P. gallaeciensis to detect, integrate, and 
respond to various environmental and physiological signals, and to adapt 
and colonize different niches in the environments [33]. 
3.1.2. TDA antibiotic mechanism and resistance 
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Although TDA is well known as a broad-spectrum antibiotic, against 
many human- and marine-pathogens, to our knowledge, the specific 
mechanism of action for this antibiotic has not yet been elucidated. Porsby 
et al. [41] reported that resistance to TDA was hard to select, and enhanced 
tolerance to TDA is difficult to gain. Further, the bacterial TDA-tolerant 
phenotype seems to confer to only low-level resistance and is very unstable. 
From this aspect, TDA is a promising broad-spectrum antimicrobial agent.  
3.2. AHL production in P. gallaeciensis  
Quorum sensing (QS) is a population-dependent chemical communication 
system used by bacteria to control various biological functions through the 
production of small signaling molecules, which interact with target cells to 
regulate the expression of sets of genes within certain bacterial species [42]. By 
far the most common intercellular signal molecules among Gram-negative are 
the N-acyl homoserine lactones (AHLs). AHLs are synthesized by a LuxI-type 
AHL synthase and directly or indirectly bind to their cognate LuxR type 
transcriptional regulator proteins, thus activating the expression of target genes 
mediating a specific response [43,44]. Homologs of LuxR and LuxI have been 
found in P. gallaeciensis genomes. The genome of strain 2.10 encodes two 
LuxI-type AHL synthases and four LuxR-type transcriptional regulators; strain 
BS107 also has two LuxI-type AHL synthases and three LuxR-type 
transcriptional regulators. PgaRI, one of the homologs of LuxRI and encoded 
by P. gallaeciensis, has been demonstrated to be important for TDA production. 
PgaR is the QS regulator and PgaI is responsible for synthesis of 
N-3-hydroxydecanoyl homoserine lactone (3OHC10-HSL) in P. gallaeciensis 
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[33,45]. Additionally, multiple putative acyl-homoserine lactone synthases 
have been found in P. gallaeciensis genomes, which indicated more than one 
AHL compound can be produced by P. gallaeciensis.  
A new class of homoserine lactones, the p-coumaroyl-homoserine lactone 
(pCA-HSL) [46], is produced by Silicibacter pomeroyi, a member of 
Roseobacter clade, in the presence of p-coumaric acid, which is secreted by 
Emiliania huxleyi, an environmentally important marine microalga [35]. 
However, at this time there are no reports demonstrating that P. gallaeciensis is 
able to produce pCA-HSL.  
3.3. Roseobacticides production in P. gallaeciensis 
P. gallaeciensis BS107 and 2.10 are symbionts associated with marine 
algae [47]. In these symbiont-host relationship, P. gallaeciensis secrete 
antibiotics and auxins that inhibit the growth of potential parasitic bacteria and 
promote algal growth [2,36,48,49], respectively. Marine algae, in turn, could 
provide a suitable surface for P. gallaeciensis colonization, and also secrete 
DMSP into the environment. DMSP attracts P. gallaeciensis, which use it as 
carbon and sulfur source [50]. However, Seyedsayamdost et al. [47] reported 
that Phaeobacter symbionts might switch to opportunistic parasites of their 
hosts due to the roseobacticides secretion from these bacteria. p-Coumaric acid, 
a small molecule secreted by microalgae, E. huxleyi, induces P. gallaeciensis to 
produce potent but selective algaecides, which are named as roseobacticides A 
and B [35]. Roseobacticides A and B are able to kill E. huxleyi, and affect two 
other microalgal strains, the cryptomonad Rhodomonas salina and the diatom 
Chaetoceros muelleri, at nM concentrations [35]. A proposed biosynthesis 
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pathway and structure of these roseobacticides were presented in recent studies 
[35]. Seyedsayamdost et al. also suggested that roseobacticide biosynthesis 
might involve an alternative use of compounds within the antibiotic and auxin 
production pathways and could transform a bacterial symbiont into an 
opportunistic pathogen [35,47].  
3.4. Indigoidine production in other Phaeobacter species 
Some Phaeobacter strains are able to produce indigoidine, an 
antimicrobial secondary metabolite, other than TDA [51]. Phaeobacter sp. 
strain Y4I produces the blue pigment indigoidine via a nonribosomal peptide 
synthase (NRPS)-based biosynthetic pathway encoded by a series of genes: 
igiBCDFE. Interestingly, the loss of indigoidine production in an igiD null 
mutant appears to have pleiotrophic effects in strain Y41. The igiD null mutant 
cells gain resistance to hydrogen peroxide, have decreased motility and 
colonize surfaces more rapidly when compared to the wild type strain [51]. 
Additionally, competitive co-cultures of V. fischeri and Phaeobacter Y4I show 
that the secretion of indigoidine by Y4I strain significantly reduces 
colonization of V. fischeri on artificial surfaces [51]. 
4. Probiotic mechanisms of P. gallaeciensis 
Probiotics used in aquaculture have been proposed to have several modes of 
action: competition for colonization sites with pathogenic bacteria, competition for 
chemicals or available energy, production of antimicrobial compounds, 
improvement of the nutritional status of host, enhancement of immune responses 
of host species and improvement of water quality [52]. Although P. gallaeciensis 
has been shown to exhibit probiotic activity on many marine organisms [6,15], the 
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probiotic mechanism (or mechanisms) has not been investigated extensively.  
TDA production has been demonstrated to play an essential role in P. 
gallaeciensis probiotic activity [1,3,10]. TDA shows inhibitory activity towards a 
wide range of human- and marine-pathogens, such as Vibrio species, Bacillus 
subtilis and Salmonella typhimurium [41]. D’ Alvise et al. [6,31] demonstrated that 
a TDA null mutant was no longer able to protect cod larvae against bacterial 
pathogens.  
Analysis of the completed genome sequences revealed that P. gallaeciensis is 
able to synthesis a siderophore [16], an iron chelating agent. Siderophores can 
dissolve precipitated iron and make it available for microbial growth. 
Non-pathogenic bacteria, which can produce siderophores, are able to compete for 
iron with pathogens, whose pathogenicity are known to be based on siderophore 
production, and outcompete other bacteria requiring iron for growth, especially 
under iron-limited environment such as ocean [52]. Holmstrøm et al. [53] reported 
that Pseudomonas fluorescens AH2 strain was able to secrete siderophores that 
efficiently chelate iron resulting in iron deprivation of the pathogen Vibrio 
anguillarum and complete growth arrest. It is reported that P. gallaeciensis 2.10 
and DSM17395 are able to secrete siderophores in laboratory conditions [16], but 
the roles of siderophore production in P. gallaeciensis on the probiotic activity has 
not been demonstrated.   
Quorum sensing has been demonstrated to regulate a diversity of 
physiological activities in Gram-negative bacteria. These processes include 
virulence, symbiosis, competence, conjugation, antibiotic production, motility and 
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biofilm formation [54]. It has been demonstrated that mutations in pgaR or pgaI 
genes caused delayed and reduced TDA production, which is important for P. 
gallaeciensis probiotic activity. Therefore, PgaRI QS system modulates TDA 
synthesis and, as a result, influence probiotic activity under specific conditions 
[55].  
Goals of this study 
Based on the current progress in P. gallaeciensis study, the overall goal of our 
research was to elucidate the probiotic mechanisms of P. gallaeciensis S4 against 
several bacterial pathogens of Eastern oyster, Crassostrea virginica, including 
Vibrio tubiashii and Roseovarius crassostreae.  
P. gallaeciensis S4 was previously isolated from inner shell surface of healthy 
oyster. The first specific aim of our study was to characterize the physiology, 
morphology and probiotic activity of the P. gallaeciensis S4 strain. A series of 
experiments were carried out to determine the growth curve, cell shape, inhibitory 
activity against pathogenic bacteria in vitro, and its probiotic activity in oyster 
larvae challenge assay in vivo. 
The second specific aim of our research was to determine the specific 
contributions and roles of tropodithietic acid (TDA) production and biofilm 
formation to the probiotic mechanisms of P. gallaeciensis S4. To investigate this 
question we constructed TDA production and biofilm formation mutant strains. 
Interactions between these mutants and pathogens on glass coverslip in vitro were 
characterized. Furthermore, these mutants were tested for their probiotic ability to 
protect oyster larvae against V. tubiashii compared to wild type S4. 
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The third specific aim of our research was determine the mechanism by which 
P. gallaeciensis S4 uses to down-regulate virulence gene expression in V. tubiashii. 
P. gallaeciensis S4 supernatant showed inhibitory activity against protease activity 
in V. tubiashii. Protease activity is regarded as the major virulence factor in V. 
tubiashii [56]. In order to elucidate the mechanism by which S4 down-regulates V. 
tubiashii virulence gene expression, effects of the S4 culture supernatant upon the 
expression of several V. tubiashii virulence genes including vtpR (a regulator of 
protease activity), vtpA (encodes metalloprotease A) and vtpB (encodes 
metalloprotease B) were determined by using qRT-PCR. Further, a 
high-throughput screen for molecules with the ability to repress the vtpB protease 
gene was developed and the active molecules were isolated and identified by using 
NMR, MS and HPLC. 
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Table 1. General genomic features of P. gallaeciensis strains 
Strain 
Length 
(kbp) 
G+C 
content 
(%) 
DNA 
scaffolds 
Number 
of 
CDSs 
Number 
of 
pseudo 
-genes 
rRNA tRNA Ref. 
2.10 4161 59.78 4 88.09 6 12 57 [16] 
DSM 
17395 
4227 59.82 4 89.04 16 12 57 [16] 
DSM 
26640 
4540 59.44 8 89.28 4 12 58 [17] 
 
CDS: coding sequence 
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Table 2. Comparison of catabolic pathway activity and origins of metabolic 
intermediates in central carbon metabolism of D. shibae, P. gallaeciensis and other 
bacteria derived from carbon labeling experiments.  
 
n.a. = not available in the organism 
PPP: pentose phosphate pathway 
EDP: Entner-Doudoroff pathway  
Pathway activity / Fractional pool composition [%] 
 
D. 
shibae 
[19] 
P. 
gallaeciensis 
[19] 
B. 
subtilis 
[23] 
B. 
megaterium 
[57] 
C. 
glutamicum 
[58] 
E. 
coli 
[22] 
Glycolysis < 1 < 1 27 46 49 73 
PPP < 1 < 1 72 49 48 22 
EDP  > 99 > 99 n.a. n.a. n.a. 4 
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Figure 1. Metabolic network of the central carbonmetabolism of Dinoroseobacter 
shibae [1] and Phaeobacter gallaeciensis [25] as predicted from the annotated 
genome sequence. G6P: glucose-6-phosphate; F6P: fructose-6-phosphate; GAP: 
glyceraldehyde-3-phosphate; PEP: phosphoenolpyruvate; PYR: pyruvate; AcCoA: 
acetyl-Coenzyme A; OGA: 2-oxoglutarate; SUC: succinate; FUM: fumarate; OAA: 
oxaloacetate; MAL: malate; 6PG: 6-phosphogluconate; KDGP: 
2-keto-3-deoxy-6-phosphogluconate; pycA: pyruvate carboxylase; pckA: 
phosphoenolpyruvate carboxykinase; ppdK: pyruvate orthophosphate dikinase. 
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Figure 2. Degradation of DMSP via (A) demethylation pathway and (B) cleavage 
pathways. FH4: tetrahydrofolate [28,29]. 
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Figure 3. Proposed model for the biosynthesis of TDA in P. gallaeciensis DSM 
17395. Integrated are the combined results of the transposon mutagenesis and the 
genome analysis presented in this study, as well as previously published data. 
Unknown reactions or ambiguities with respect to enzyme functions are indicated 
by question marks. Chemical structures: (1) phenylalanine; (2) phenylpyruvate; (3) 
phenylacetate; (4) phenyacetyl-CoA; (5) ring-1,2-epoxyphenylacetyl-CoA; (6) 
2-oxepin-2(3H)-ylideneacetyl-CoA(oxepin-CoA); (7) 3-oxo-5,6- 
dehydrosuberyl-CoA semialdehyde; (8) 2-hydroxycyclohepta-1,4,6-triene 
-1-formyl-CoA; (9) tropolone; (10) tropone and (11) thiotropocin. Gene and 
protein names: cobA2: uroporphyrinogen-III C-methyltransferase; cysE: serine 
acetyltransferase; cysH: phosphoadenosine phosphosulfate reductase; cysI: 
putative sulfite reductase; cysK: cysteine synthase; hisC: histidinol-phosphate 
aminotransferase; ior1: indole pyruvate oxidoreductase (fused); paaA: 
ring-1,2-phenylacetyl-CoA epoxidase; paaC: ring-1,2-phenylacetyl-CoA epoxidase; 
paaD: ring-1,2-phenylacetyl-CoA epoxidase; paaE: ring-1,2-phenylacetyl-CoA 
epoxidase; paaF: 2,3-dehydroadipyl-CoA hydratase; paaG: 
ring-1,2-epoxyphenylacetyl-CoA isomerase (oxepin-CoA forming)/postulated 
3,4-dehydroadipyl-CoA isomerase; paaH: 3-hydroxyadipyl-CoA dehydrogenase ; 
paaJ: 3-oxoadipyl-CoA/3-oxo-5,6-dehydrosuberyl-CoA thiolase; paaK1, paaK2: 
phenylacetate-CoA ligase; paaZ2: enoyl-CoA hydratase; patB: cystathionine 
betalyase; sat/cysC: putative bifunctional SAT/APS kinase; serB: phosphoserine 
phosphatase; serC: phosphoserine aminotransferase; tdaA: transcriptional regulator, 
LysR family; tdaB: -etherase; tdaC: prephenate dehydratase domain protein; tdaE: 
acyl-CoA dehydrogenase; tdaF: putative flavoprotein, HFCD family; thiG: thiazole 
biosynthesis protein and tyrB: aromatic amino-acid aminotransferase. 
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ABSTRACT 
Bacterial pathogens, including several Vibrio spp. and Roseovarius 
crassostreae cause severe mortality of larval and juvenile Eastern oysters. The 
introduction of beneficial bacterial isolates in oyster hatcheries and nurseries for 
the biocontrol of bacterial diseases is a good alternative to the use of antibiotics. 
The goal of this study was to screen and characterize marine bacterial isolates as 
potential agents to prevent larval and juvenile mortality by the oyster pathogens V. 
tubiashii and R. crassostreae. Screening of bacterial isolates from Rhode Island 
marine organisms and environment using agar-based assay methods for detection 
of antimicrobial activity against oyster pathogens led to the isolation of candidate 
probionts Phaeobacter sp. S4 and Bacillus pumilus RI06-95. Pretreatment of larval 
and juvenile oysters for 24 h with 102 to 106 CFU ml-1 of Phaeobacter sp. S4 or B. 
pumilus RI06-95 protected larval oysters against mortality due to challenge with R. 
crassostreae and V. tubiashii (Relative Percent Survival, RPS, ranging from 9% to 
56%). These probiotics also protected juvenile oysters against challenge with V. 
tubiashii (RPS 37 – 50%). Probiotic isolates had no negative impact on oyster 
survival. Protection conferred to larvae against bacterial challenge was short-lived, 
lasting only for 24 h after removal of the probiotics from the incubation water. 
These results suggest the potential of marine bacterial isolates Phaeobacter sp. S4 
and B. pumilus RI06-95 to serve as biocontrol agents to reduce the impact of 
bacterial pathogens in the culture of C. virginica.
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INTRODUCTION 
The Eastern oyster, Crassostrea virginica (Gmelin), a bivalve species of 
the Gulf of Mexico and Atlantic coasts of North America, has significant 
economical and ecological value (Kennedy et al. 1996). However, this species 
suffers from the impact of different bacterial and parasitic diseases causing high 
mortalities in cultured and wild populations (Lee et al. 1996, Burreson & Ford 
2004, Villalba et al. 2004). Bacterial infections are considered as a major problem 
for the shellfish aquaculture industry, causing mass mortality especially during 
larval and juvenile stages (Paillard et al. 2004). The pathogens Roseovarius 
crassostreae and several Vibrio spp. are amongst the major causative agents of 
bacterial disease in the culture of the Eastern oyster. As the causative agent of 
Juvenile or Roseovarius Oyster Disease (ROD), Roseovarius crassostreae causes 
high seasonal mortalities of oyster juveniles in the Northeast US (Boettcher et al. 
2005, Maloy et al. 2007). Meanwhile, Vibrio tubiashii is a reemerging pathogen 
that causes vibriosis and severe losses of production in oysters during the larval 
stages (Tubiash 1965, Elston et al. 2008). 
Disease outbreaks in shellfish aquaculture are managed using methods such 
as disease avoidance, frequent water changes, good husbandry, and the use of 
immunostimulants and antibiotics (Elston and Ford 2011). Antibiotics have been 
widely used in aquaculture systems as a method for disease control. However, due 
to the emergence of antibiotic resistance and concerns about environmental 
pollution, alternatives to the use of antibiotics are needed (Austin 1985, Vershuere 
et al. 2000). One of these alternative methods is the use of non-pathogenic 
microorganisms called probiotics. 
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 A probiotic is generally defined as a live microbial food supplement 
which, when administered in a sufficient amount, confers a health benefit on the 
host (FAO 2006). In aquaculture, probiotics can be administered either as a food 
supplement or as an additive to the water (Moriarty 1998). Probiotics in 
aquaculture have been proposed to have several modes of action: improvement of 
water quality, enhancement of immune responses of host species, enhancement of 
nutrition of host species through the production of supplemental digestive 
enzymes, competition for space with pathogenic bacteria, and production of 
antimicrobial compounds (Kesacordi-Watson et al. 2008, Thompson et al. 1999, 
Verschuere et al. 2000). The potential for the beneficial impact of the use of 
probiotic bacteria on shellfish aquaculture has been shown for many different 
species, including oysters. Douillet and Langdon (1994) demonstrated that Pacific 
oyster larvae fed with algae and Alteromonas sp. show increased survival and 
growth compared with treatments fed with algae alone. The authors suggest that 
the bacteria may act as an essential nutrient to the larvae, which is not provided by 
the algae. Gibson et al. (1998) successfully isolated a bacterium producing 
bacteriocin-like inhibitory substances capable of inhibiting the growth of several 
pathogenic bacteria. This probiont, identified as Aeromonas media A199, 
significantly inhibits the growth of V. tubiashii in the culture of Pacific oyster 
larvae. The addition of Vibrio sp. probiotic candidate OY15 provides a beneficial 
effect in the culture of C. virginica larvae with and without the presence of the 
shellfish pathogen Vibrio sp. B183 (Kapareiko et al. 2011). Most recently, the use 
of Pseudoalteromonas sp. D41 and Phaeobacter gallaeciensis were found to 
provide 50% and 40% improved survival respectively in Pacific oyster larvae after 
being challenged with Vibrio coralliilyticus (Kesarcodi-Watson et al. 2012). The 
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introduction of selected beneficial bacterial isolates for biocontrol of R. 
crassostreae and vibriosis may help in combating diseases in the culture of Eastern 
oysters. 
In this study, two potential probionts were isolated from two different local 
sources in Rhode Island. A Gram negative Phaeobacter sp. S4 was isolated from 
the inner shell of oysters and a Gram positive Bacillus pumilus RI06-95 was 
isolated from a marine sponge from Narrow River, a tidal estuary in Narragansett 
Rhode Island. Both of these candidate probionts showed promising results during 
in vitro screening of antibiotic activity against oyster and fish pathogens, as well as 
protecting larval and juvenile during in vivo challenge experiments with two oyster 
bacterial pathogens (V. tubiashii RE22 and R. crassostreae CV 919-312T). We also 
describe the length of the protection conferred by the probiotic treatment. 
MATERIALS AND METHODS 
Bacterial strains 
Bacterial strains Vibrio tubiashii RE22 (Hasegawa et al. 2008) and R. 
crassostreae Cv919-312T (Boettcher et al. 2005) were kindly supplied by H. 
Hasegawa, Department of Biomedical Sciences, Oregon State University (USA), 
and K. Boettcher, formerly at the University of Maine (USA), respectively. Strain 
V. harveyi BB120 (Bassler et al. 1997) was obtained from B. Bassler (Princeton 
University, USA). The marine bacteria Phaeobacter sp. S4 and Bacillus pumilus 
RI05-95 were identified as potential probiotics using the in vitro plate assays 
described below. The isolates were characterized to the level of species using 16S 
rDNA sequence analysis (Gauger and Gómez-Chiarri 2002) (GenBank Accession 
nus. KO625490 and KC625491). All the isolates were maintained and stored in 50 
% glycerol stocks at -80°C. Probiotic candidates and pathogens were routinely 
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grown overnight in yeast peptone with 3% NaCl (YP3) broth (5 g L-1 of peptone, 1 
g L-1 of yeast extract, 30 g L-1 of ocean salt, Instant Ocean) at 27 °C (V. tubiashii, 
V. harveyi, and R. crassostreae) or 25°C (B. pumilus RI06-95) with shaking.  
In vitro screening of probiotic candidates 
A bacterium-bacterium competition assay described by Teasdale et al. 
(2009) was used in this assay with several modifications. In the ‘colony on top’ 
assay, 5 ml of 0.8% of YP3 soft agar containing 50 µl of approximately 108 CFU 
ml-1 of the pathogen from an overnight culture was poured atop YP3 agar plates. 
After the agar cooled, 2 µl of a solution of about 108 CFU ml-1 of the candidate 
probiotic from an overnight culture was spotted onto the plate and incubated at 27 
°C for 12 – 16 h before the inhibition zones were measured. For the ‘membrane 
overlay’ assay, an aliquot of 2 µl of a solution of approximately 108 CFU ml-1 of 
the candidate probiotic was spotted onto YP3 agar plates and incubated at 27 °C 
for 48 h. After incubation, a sterile 12-14 kDa molecular-weight-cutoff (MWCO) 
dialysis membrane (Spectra/Por; Spectrum Medical Industries, Inc., Houston, TX) 
was laid atop the colonies and covered with 6 ml of 0.8% YP3 agar containing 60 
µl of approximately 108 CFU ml-1 of pathogen from an overnight culture. Plates 
were incubated at 27 °C for 12 - 16 h after agar solidification and the diameter of 
the clear (inhibitory) zones around the probiont colonies were measured using a 
ruler. 
Characterization of Phaeobacter sp. S4 growth and morphology 
Single colonies of Phaeobacter sp. S4 were inoculated into YP3 media, 
grown for 48 h at 27 ˚C with shaking, and then backdiluted into fresh YP + 2% 
NaCl (YP2) or YP3 media at a 1: 1000 dilution. Cultures were incubated at 27˚C 
with shaking for up to 72 h and aliquots were taken at selected time points to 
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determine bacterial concentration (CFU ml-1) by plating of serial dilutions. 
Aliquots of bacterial cells taken from cultures grown to late exponential (36 h) and 
stationary (48 h) phases were placed on glass coverslips and examined by phase 
contast microscopy at the Rhode Island Genomics and Sequencing Center at the 
University of Rhode Island with a Zeiss Axio Imager 2 microscope using phase 
contrast optics. Biofilm-containing samples were grown in static culture conditions 
for 48 h at 27C and scraped from the walls of the glass culture tubes (15  150 
mm) before being placed on glass slides and observed by phase contrast 
microscopy. 
Preparation of bacterial isolates for challenge 
 Candidate probiotics and pathogens were cultured overnight with shaking in 
10 ml YP3 broth. Overnight cultures were transferred to 50 ml sterile Falcon tubes 
and centrifuged at 2,300 x g for 10 min to harvest the cells. Cells were washed 
twice with 10 ml of filtered sterile seawater (FSSW) and the cell pellet was 
resuspended in 10 ml FSSW and mixed using a vortex mixer. The bacterial density 
was determined by measuring optical density at 550 nm using a spectrophotometer 
(SynergyTM HT, BioTek, USA) and assuming that an optical density of 1.000 
corresponds to 1.2 x 109 CFU ml-1 according to the McFarland standard 
(BioMerieux, Marcyl’Etoile, France). After the concentration of the bacteria was 
determined, the bacterial suspension was diluted to the target concentration in 
FSSW. The final target concentration was confirmed by plating serial dilutions of 
the bacterial cultures for each treatment on the appropriate agar plates and counting 
colony forming units (CFU) after overnight incubation at 25 or 27 C. The 
commercial probiotic mix (Sanolife  MIC, INVE Aquaculture, Belgium) was 
mixed by adding 0.1 g of Sanolife in 50 ml of FSSW following the manufacturer’s 
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protocol. The solution was then adjusted to a stock concentration of 5 x 106 CFU 
ml-1 and used at a target concentration of 104 CFU ml-1. 
Larval oyster bacterial challenges 
 Experimental challenges were performed as previously described 
(Gómez-León et al. 2008) with minor modifications. Larvae of Eastern oysters 
Crassostrea virginica (12 to 20 days of age, 50 – 150 µm in size) were obtained 
from the Blount Shellfish Hatchery at Roger William University (Bristol, RI, 
USA). Oysters (25 to 30 larvae) were placed in each well of a 6 well plate 
containing 5 ml of FSSW at 28 psu. The candidate probiotics isolates S4 and 
RI06-95 were added to the wells at final concentrations ranging from 102 to 106 
CFU ml-1. The commercial probiotic Sanolife MIC was used at a final 
concentration of 104 CFU ml-1.  Larval oysters were fed with commercial algal 
paste (20,000 cells ml-1; Reed Mariculture Inc., San Jose, CA, USA) in order to 
promote ingestion of the probiotics. Plates were incubated at 22-23°C for 24 h with 
gentle rocking. Water in the wells was then changed to remove the probiotics. 
Either V. tubiashii RE22 or R. crassostreae CV919-312T was added to 5 ml of 
FSSW containing the larvae to achieve the target concentration of pathogen (105 or 
106 CFU ml-1). Control wells included non-treated larvae (with and without 
pathogen) and larvae incubated with probiotics but not with the pathogen. Each 
treatment was run in triplicate. Larval survival was determined 24 h after addition 
of the pathogen by adding 200 μl of neutral red to each well to a final 
concentration of 0.53 mg l-1 and incubation for 2 h before counting living and dead 
oysters. The neutral red staining technique distinguishes between live (stained) and 
dead (not stained) larvae (Figure 1; Gómez-León et al., 2008). The survival rate 
was calculated by using the formula:  Survival rate (%) = 100 x (number of live 
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larvae/total number of larvae). The Relative Percent Survival (RPS) (Amend 
1981) conferred by the probiont (treatment) with respect to the challenged larvae 
(control) was calculated by using the formula:  RPS (%) = [1 – (% mortality 
treatment / % mortality control)] x 100. These experiments were run at least 3 
times in triplicate for the candidate probionts S4 and RI06-95, once for the 
commercial probiont Sanolife MIC. 
Length of protection conferred by candidate probionts 
 Larval oysters were placed in 6-well plates containing 5 ml of FSSW and 
candidate probionts were introduced to a final concentration of 104 CFU ml-1. 
Plates were incubated at 22-23°C for 24 h with gentle rocking. At 24 h of 
incubation, FSSW was removed from the wells and exchanged with 5 ml of FSSW 
without the probiotics. Pathogen V. tubiashii RE22 (final concentration of 105 CFU 
ml-1) was applied to the wells 24, 72, or 120 h after addition of the candidate 
probionts (equivalent to 0, 48, or 96 h after removal of the probiont). Larval oyster 
survival and RPS was determined as described above after 24 h of incubation with 
the pathogen. Larval oysters were fed daily with commercial algal paste (20,000 
cells ml-1). This assay was run only once with each treatment tested in triplicate. 
Juvenile oyster bacterial challenges 
 Ten juvenile oysters (8 – 15 mm in shell height) per container were placed in 
500 ml buckets containing 200 ml of FSSW and each container was provided with 
continuous aeration via airstones. Candidate probionts were applied at a final 
concentration of 105 CFU ml-1 and containers were incubated at 22-23°C for the 
length of the experiment. After 24 h of incubation with the probiont, V. tubiashii 
RE22 was applied to a final concentration of 105 CFU ml-1. Mortalities were 
recorded every 2 - 3 d for 13 d and cumulative % survival was calculated. Water 
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was exchanged every 2 - 3 d and the oysters were fed daily with commercial algal 
paste (20,000 cells ml-1). This experiment was performed once using duplicate 
containers per treatment.  
Statistical Analysis 
Survival and cumulative mortality data were analyzed using One or Two 
Way Analysis of Variance (ANOVA) and multiple comparison tests (Tukey test) 
was used to determine significance between groups. Data collected as percentage 
were arcsine of the square root-transformed before analysis. Results were 
considered significant at 95% level of confidence (p<0.05). All the statistics were 
run using Sigmastat 3.1 software (Systat). 
RESULTS 
Antibiotic activity against bacterial pathogens 
In this study, amongst 64 bacteria strains isolated from the inner shell of 
healthy oysters, only Phaeobacter sp. S4 was found to have an antibiotic activity 
against V. harveyi BB120 by using two different plates assays. In the ‘membrane 
overlay’ assay, the use of the membrane prevents direct contact between probiont 
and pathogen, only allowing chemicals with a molecular mass <12-14 kDa to go 
through. This method allows observation of chemical interactions between 
probiont and pathogen. Meanwhile, the ‘colony on top’ assay allows for direct 
bacterial interaction between probiont and pathogen. The probiont candidate 
Bacillus pumilus RI06-95 inhibited the growth of pathogens V. harveyi BB120 at 
27 °C and R. crassostreae CV 919-312T at 20 and 27 °C using both the ‘colony on 
top’ and the ‘membrane overlay’ assays (Table 1). This isolate, however, showed 
no growth inhibitory activity against V. tubiashii RE22. The candidate probiont 
Phaeobacter sp. S4 inhibited the growth of all pathogens with the exception of V. 
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tubiashii RE22 at 20°C in the ‘colony on top’ assay (Table 1). Differences in the 
pattern of inhibition between the two assays for this probiont are probably due to 
differences in the length of the incubation times of the probiotic with the pathogen 
(12 - 16 h for the ‘colony on top’ and 48 h for the ‘membrane overlay’). 
Characterization of Phaeobacter sp. S4 growth and morphology.   
We characterized Phaeobacter sp. S4 with regard to some basic properties 
that might affect its ability to serve as a probiotic organism in marine aquaculture, 
namely growth curves in marine media and the ability to form biofilms. Briefly, S4 
grew well in YP + 2% or 3% NaCl at temperatures from 18C up to 30C (not 
shown). Cells were unable to grow at 37C. At 27C there was no difference in the 
growth rate of S4 when cells were grown in either YP2 or YP3 (Figure 2). The 
average doubling time for each condition was 3.1 h for YP2 and 3.2 h for YP3. 
The final density of S4 in either YP2 or YP3 was ~2.0  109 CFU ml-1. 
While growth in 2% and 3% NaCl produces virtually identical growth rates 
and final cell densities, these two conditions resulted in two different morphologies 
for Phaeobacter sp. S4 (Figure 3). Growth in YP3 results in small, ovoid motile 
cells (Figure 3a), that when entering stationary phase form rosettes. Cells grown in 
YP2 elongate to spindle-shaped cells during late stationary phase, lose motility, 
and form rosettes (Figs. 3b,c). If grown in static culture, the cells formed a thick 
biofilm on glass surfaces (Figure 3d). Plastic surfaces (polycarbonate, polystyrene, 
and polypropylene) did not support the formation of a biofilm by S4 (not shown).  
Effect of pre-treatment with probiotics on larval oysters’ survival to bacterial 
challenge 
Candidate probionts were not pathogenic to the host since the survival of 
oyster larval treated with the candidate probionts was not significantly different to 
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the control (Figure 4). Rapid deaths of larval oysters were seen after exposure to 
pathogens V. tubiashii RE22 and R. crassostreae CV 919-312T for 24 h, with 
survival ranging from 14 - 31% depending on the pathogen and dose (>80% for 
unchallenged controls). Survival of oysters pre-treated with candidate probionts for 
24 h and then exposed to the bacterial pathogens were significantly higher than 
those of larvae that had not been exposed to the probiont, increasing from a 
survival of 14 - 31% for non-treated larvae to 32 – 64% for probiotic-treated larvae 
(Figure 4).   
The level of protection was different depending on the relative 
concentrations of candidate probionts and pathogen added (Table 2). Candidate 
probiont Phaeobacter sp. S4 was found to protect larval oysters more effectively 
against V. tubiashii RE22 than against R. crassostreae CV 919-312T. This study 
also demonstrated Phaeobacter sp. S4 gave higher levels of protection against both 
pathogens than B. pumilus RI06-95. The optimal concentration for probionts 
Phaeobacter sp. S4 and B. pumilus RI6-95 was 104 CFU ml-1. At this 
concentration, both probiotics were able to confer significant survival against V. 
tubiashii RE22 (p<0.05) and R. crassostreae CV 919-312T (Table 2). On the other 
hand, no protection effect was found in larval oysters treated with commercial 
probiotic Sanolife MIC (INVE, Belgium) after challenge with V. tubiashii RE22 
(survival of challenged larvae pretreated with Sanolife MIC of 2 ± 2 % compared 
to 98 ± 2 % for non-challenged larvae pretreated with Sanolife MIC, Table 2). 
Length of protection conferred by probiotics 
In order to determine the duration of protection provided by a 24 h 
exposure of larval oysters to the candidate probionts, we determined the survival of 
larval oysters challenged at different time points after exposure to the probionts (0, 
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48, and 96 h after removal of the candidate probionts). As observed above, larval 
oysters incubated with probionts for 24 h were significantly protected against a 24 
h bacterial challenge with V. tubiashii when the pathogen was added immediately 
after the removal of the probiont (Figure 5). However, no significant protection 
was obtained when the larvae were challenged 48 and 96 h after removal of the 
probionts. The Relative Percent Survival of larval oysters exposed to Phaeobacter 
sp. S4 for 24 h dropped significantly from 78% when oysters were challenged 
immediately after removal of the probiont to 14% and 13% when oysters were 
challenged 48 and 96 h after removal of the probiont. The RPS of larval oysters 
exposed to B. pumilus RI06-95 dropped from 44% when oysters were challenged 
right after removal of the probiont to 1% (challenged at 48 h) and 4% (challenged 
at 96 h). 
Effect of pre-treatment with probionts on juvenile oysters survival to bacterial 
challenge  
 We wanted to determine whether exposure to the probiotic bacteria would 
protect juvenile oysters from V. tubiashii in a manner similar to what was observed 
for larval oysters.  While juvenile oysters showed a sharp increase in mortalities 
on day 6 after challenge with V. tubiashii RE22, oysters in containers to which 
probiotic strains were added 24 h before challenge showed relatively low levels of 
mortality (less than 15%) until day 8 after challenge (Figure 6). At the end of the 
assay (13 d), exposure to the probionts significantly reduced juvenile oyster 
mortalities after challenge with V. tubiashii (p<0.05; RPS, B. pumilus RI06-95:  
60 ± 0 % and Phaeobacter sp. S4:  67 ± 0 %). Co-incubation of juvenile oysters 
with both S4 and RI06-95 did not confer added levels of protection compared to 
preincubation with either one of the probiotics alone (p>0.05). 
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DISCUSSION 
This study successfully identified two potential bacterial candidates to be 
used as probiotics for disease management control in oyster aquaculture. Bacterial 
strains Phaeobacter sp. S4 and B. pumilus RI06-95 were selected as candidate 
probionts due to their antagonistic properties against the oyster pathogens R. 
crassostreae and V. tubiashii, and also the marine finfish and shellfish pathogen V. 
harveyi. We demonstrate here that they also conferred significant protection to 
larval oysters against experimental bacterial challenge. Furthermore, preincubation 
of juvenile oysters with these probionts led to significantly improved survival of 
juvenile oysters 13 days after challenge with V. tubiashii.  
These two candidate probionts were able to protect oyster larvae and 
juveniles against the severe bacterial challenges used in our research, and show the 
potential to provide protection when used prophylactically in hatcheries, where the 
levels of pathogenic bacteria in seawater sometimes approach levels similar to the 
challenge doses used in our experiments (Elston et al. 2008). The bacterial 
pathogens V. tubiashii and R. crassostreae cause rapid mortalities in larval oysters 
in our experiments; oysters stopped swimming and most of the tissue was 
completely digested leaving an empty shell after 24 h of exposure to the pathogens. 
This is consistent with previous research on these pathogens (Elston et al. 2008, 
Gibson et al. 1998, Gómez-León et al. 2008).   
The candidate probionts we have tested here are commensals of marine 
organisms and proved in our experiments to be safe to larval and juvenile oysters, 
since they had no significant effect on larval or juvenile survival at the 
concentrations tested (up to 106 CFU ml-1). Although we have not direcly tested 
the effect of these probionts on algal cultures, previous research on another 
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Phaeobacter sp. (Phaeobacter galleciensis) with probiotic activity on cod larval 
cultures showed no negative effects of this probiont on the survival of the 
microalgae Tetraselmis suecica, a species commonly used in aquaculture 
hatcheries (D’Alvise et al. 2012). Our experiments also showed that significant 
levels of protection were obtained with a dose of probiotic of 104 CFU ml-1, a dose 
easily achievable even in the large culture tanks used at commercial hatcheries. 
The length of protection conferred to larval oysters by exposure to the probionts, 
however, is short-term (24 h), suggesting that these probiotics may need to be 
supplied to larvae in the hatcheries daily to maintain their effectiveness. This is not 
uncommon for other probiotics, which are usually provided daily with the feed to 
host organisms to provide maximum benefits (Kesacordi-Watson et al. 2008, 
Verschuere et al. 2000). Interestingly, a single dose of probiotics added to the 
culture water of juvenile oysters 24 h prior to bacterial challenge provided 
significant levels of protection for at least 13 days, suggesting that the probionts 
may persist longer in juvenile oysters compared to larval oysters, or that additional 
mechanisms of protection are involved in juvenile oysters. More research should 
be done to determine the effectiveness and mechanisms of action of these probiotic 
bacterial strains in different developmental stages of oysters and different growing 
conditions. 
Our study showed that lack of growth inhibitory activity in vitro towards a 
particular pathogen is not necessarily predictive of how a candidate probiont would 
perform in vivo. Candidate probiont Bacillus pumilus RI06-95 was not able to 
inhibit the growth of V. tubiashii in vitro but showed a protective effect toward 
larval and juvenile oysters during in vivo challenge, suggesting that protection 
conferred by B. pumilus RI06-95 against V. tubiashii may not be due to antibiotic 
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activity or that the in vitro assays used in the screening process do not predict the 
production of the antibiotic in vivo. Probiotics are able to improve survival of the 
hosts by different mechanisms (Kesacordi-Watson et al. 2008, Verschuere et al. 
2000). Beside secretion of antibiotic compounds, it is known that probiotics are 
capable of various other modes of action that give benefits to the host. In previous 
research, Bacillus sp. S11 has been reported to improve health by stimulating the 
immunity of the host organism (Rengpipat et al. 2000). This may be one of 
potential mechanism provided by B. pumilus RI06-95 in order to protect the 
oysters against V. tubiashii in our in vivo assay. This probiotic may also promote 
enhanced digestion in oysters. Research by Olmos et al. (2011) demonstrated the 
ability of B. subtilis to enhance carbohydrate digestion and improve the health of 
the shrimp Litopenaeus vannamei. Furthermore, Sun et al. (2010) demonstrated 
that grouper Epinephelus coioides consumed dietary nutrients better after 
supplementing the feed with B. pumilus or B. clausii.  
In contrast, the results from the in vitro tests with Phaeobacter sp. S4 
showed growth inhibitory activity against the two oyster pathogens and this 
coincided with increased protection seen in the in vivo assays. Research performed 
by Porsby et al. (2008) showed that members of Roseobacter clade such as 
Phaeobacter gallaeciensis and P. inhibens produce an antibiotic compound named 
tropodithietic acid (TDA), capable of inhibiting the growth of the bacterial 
pathogens Vibrio anguillarum, V. splendidus, V. cholerae, B. subtilis, and 
Halomonas spp. Furthermore, the application of bacterial cultures or cell extracts 
of Phaeobacter spp. improve survival of fish larvae (Makridis et al. 2005; Planas 
et al. 2006) and shellfish (Balcázar et al. 2007; Ruíz-Ponte et al. 1999) in rearing 
tanks. Recently, D’Alvise et al. (2012) demonstrated the ability of P. galleciensis 
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to protect cod larvae from vibriosis. Besides producing TDA, Phaeobacter spp. are 
known as primary colonizers of various inorganic and organic marine surfaces, 
including marine algae and dinoflagellates (Dang and Lovell, 2002; Mayali et al. 
2008). Our observations of this bacterium confirm that Phaeobacter sp. S4 avidly 
forms rosettes and biofilms on inorganic surfaces, such as glass. Further, our 
results showing the ability of a Phaeobacter sp. isolated from the inner side of an 
adult oyster shell (and probably a member of the natural oyster microbiome) to 
protect larval oysters from bacterial challenge provide further evidence of the 
potential of Phaeobacters as probiotic species. 
In conclusion, these studies successfully isolated two candidate probionts 
for diseases management in oyster hatcheries. Phaeobacter sp. S4 is a good 
probiont candidate showing clear antibiotic activity in vitro and protection in vivo. 
The relationship between probiotic activity in vivo and antibiotic activity in vitro, 
however, is not so strong in the case of protection of larval oysters against V. 
tubiashii conferred by B. pumilus RI06-95, suggesting that other mechanisms 
contribute to probiotic activity. Thus, in addition to good candidates for use in 
shellfish aquaculture, these candidate probionts will be useful in evaluating the 
relationship between antibiotic and probiotic activities in order to help establish 
rational strategies for the screening for potential probiotics. 
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Table 1: Antibiotic activity of candidate probionts Phaeobacter sp. S4 and Bacillus 
pumilus RI06-95 against selected bacterial pathogens of finfish (Vibrio harveyi 
BB120) and shellfish (V. tubiashii RE22 and Roseovarius crassostreae 
CV919-312T) as determined by 2 plate diffusion assays at 2 temperatures. The 
antibiotic activity is reported as the diameter of the inhibition zone in mm ± 
standard error of the mean (SEM), including the size of the colony for the 
candidate probiont (3 mm). 
Colony-on-top (mm) Membrane overlay (mm) Probiotics 
Temp. BB120 RE22 CV919-312T BB120 RE22 CV919-312T 
RI06-95  
20°C 
- 0 11 ± 1 - 0 4 ± 1 
RI06-95  
28°C 
10 ± 1 0 13 ± 1 7 ± 1 0 5 ± 1 
S4 20°C - 0 16 ± 0 - 6 ± 1 15 ± 1 
S4 28°C 6 ± 1 7 13 ± 1 6 ± 1 6 ± 1 13 ± 2 
- = Not Tested  
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Table 2. Effect of preincubation with candidate probionts Bacillus pumilus 
RI06-96, Phaeobacter sp. S4, and commercial probiotic mix Sanolife MIC (INVE 
Aquaculture, Belgium) on larval oyster survival 24 h after challenge with bacterial 
pathogens Roseovarious crassostreae CV919-312T and Vibrio tubiashii RE22. The 
candidate probionts were introduced 24 h before larvae were challenged. Data are 
expressed as Relative Percent Survival (RPS, % ± SEM) of challenged oysters 
pre-treated with probiotic to control challenged oysters. Different letters in 
superscript indicate statistical differences between treatments for each probiont (1 
way ANOVA, p<0.05) 
Relative Percent Survival (RPS, %) 
Probiotics and concentration (CFU/ml) 
RI06-95 S4 INVE 
Bacterial 
pathogens and 
concentration 
(CFU ml-1) 
106 104 102 106 104 102 106 
106 31 ± 2a - - 53 ± 3b  - - - 
RE22 
105 29 ± 3a 29 ± 3a - 44 ± 3b 55 ± 2b - 0 
106 11 ± 2x - - 14 ± 3x - - - CV919-
312T 105 22 ± 2y 42 ± 3z 20 ± 1xy 43 ± 5z 49 ± 3z 29 ± 2y - 
 (-) Not tested.  RPS (%) = [1 – (% survival control / % survival treatment)] x 100. 
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Figure 1. Effect of preincubation with candidate probiont Phaeobacter sp. S4 on 
the morphology of larval oysters 24 h after challenge with the bacterial pathogen 
Vibrio tubiashii RE22. The candidate probionts were introduced 24 h before 
pathogen challenge. (A) Larva challenged with RE22 showing clumping of cilia 
(arrow). (B) Group of larva challenged with RE22, showing cell debris 
(arrowhead) and dead larvae as indicated by empty shells not stained with neutral 
red (arrow). (C & D) Larvae preincubated with S4 and challenged with RE22 were 
viable, showing staining with neutral red (arrow) and normal cilia (arrowhead). 
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Figure 2. Growth curve of Phaeobacter sp. S4 in YP2 and YP3 at 27C. Cells were 
grown for 48 h in YP3 and then back diluted into fresh YP2 () or YP3 () at a 1: 
1000 dilution.  Samples were taken at the indicated times and the cell density 
determined by serial dilution and plating onto YP3. 
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Figure 3. Phase contrast micrographs showing the morphology of Phaeobacter sp. 
S4 in different growth phases. (A) Late exponential phase cells grown in YP3; (B) 
Late exponential phase cells grown in YP2; (C) YP2-grown cells in rosettes; (D) 
S4 cells grown in YP2 in a biofilm. Size bar = 10 m. 
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Figure 4. Effect of preincubation of larval oysters with candidate probionts 
RI06-95 and S4 at 104 CFU ml
-1
 on survival (%± SEM) 24 h after challenge with 
bacterial pathogens Roseovarious crassostreae CV919-312T and Vibrio tubiashii 
RE22 at 105 CFU ml-1. The candidate probionts were introduced 24 h before larvae 
were challenged. Representative of at least 3 experiments; different letters indicate 
statistical significance between groups (One Way ANOVA, p<0.05).    
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Figure 5. Length of protection to bacterial challenge provided by preincubation of 
larval oysters with candidate probionts RI06-95 and S4. Larval oysters were 
preincubated for 24 with 104 CFU ml-1 of the probiont, washed, placed in filtered 
sterile seawater and then challenged by adding 105 CFU ml-1 of pathogen Vibrio 
tubiashii RE22 0, 48, or 96 h after removal of the probionts. Different letters 
indicate statistical significance between treatments and times (2 way ANOVA, 
p<0.05). 
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Figure 6. Effect of preincubation of juvenile oysters with candidate probionts on 
oyster survival after bacterial challenge. Oysters were preincubated with 104 CFU 
ml-1 of probionts Bacillus pumilus RI06-95 or Phaeobacter sp. S4 for 24h, then 105 
CFU ml-1 of pathogens Vibrio tubiashii RE22 were added to the incubation 
seawater and survival was determined every 2 – 3 days for 13 days. Different 
letters indicate statistical significance between treatments (One way ANOVA, 
p<0.05).  
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Abstract 
The probiotic bacterium Phaeobacter gallaeciensis strain S4Sm, isolated from the 
inner shell surface of a healthy oyster, secretes the antibiotic tropodithietic acid 
(TDA), is an excellent biofilm former, and increases oyster larvae survival when 
challenged with bacterial pathogens. In this study, we investigated the specific 
roles of TDA secretion and biofilm formation in the probiotic activity of S4Sm. 
For this purpose, mutations in clpX (ATP-dependent ATPase) and exoP (an 
exopolysaccharide biosynthesis gene) were created by insertional mutagenesis 
using homologous recombination. Mutation of clpX resulted in the loss of TDA 
production, no decline in biofilm formation, and loss of the ability of S4Sm to 
inhibit the growth of Vibrio tubiashii and Vibrio anguillarum in vitro. Mutation of 
exoP resulted in a ~70% decline in biofilm formation, no decline in TDA 
production, and delayed inhibitory activity towards Vibrio pathogens in vitro. Both 
clpX and exoP mutants exhibited reduced ability to protect oyster larvae from 
death when challenged by Vibrio tubiashii. Complementation of the clpX and exoP 
mutations restored the wild type phenotype. We also found that pre-colonization of 
surfaces by S4Sm was critical for this bacterium to inhibit pathogen colonization 
and growth. Our observations suggest that probiotic activity by S4Sm involves 
contributions from both biofilm formation and the production of the antibiotic 
TDA.  
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Introduction 
Infections by pathogenic marine bacteria are a major problem for both the 
shellfish and finfish aquaculture industries, causing severe disease and high 
mortality, which seriously affect aquaculture production and cause significant 
economic loss [1]. This problem particularly affects the survival and growth of fish 
and shellfish during the larval and juvenile stages [1,2]. Opportunistic pathogens 
from the Vibrionaceae and at least one member of the Roseobacter clade cause 
disease in a variety of shellfish [3-5]. For example, Vibrio tubiashii, a reemerging 
pathogen of larval bivalve mollusks that causes invasive and toxigenic disease has 
been responsible for massive mortalities among larval oysters in hatcheries on the 
west coast of the United States [5]. Additionally, Roseovarius crassostreae, a 
member of the Roseobacter clade and the causative agent of juvenile or 
Roseovarius oyster disease (JOD or ROD), infects juvenile oysters in the summer 
when water temperatures are 20C causing high mortalities [6]. Although 
antibiotics and vaccines can be used to control some infectious diseases in 
aquaculture, they have some distinct disadvantages and limitations. Use of 
antibiotics increases the risk of development and transfer of antibiotic resistance 
[7]. Vaccines, which rely on an adaptive immune response, are only effective for 
vertebrate organisms and cannot be used to protect shellfish [8]. 
Probiotics represent a promising alternative strategy to control infection and 
some probiotic strains are already used commonly in aquaculture as biological 
control agents in finfish and shellfish [9,10]. For example, the probionts Bacillus 
subtilis and Bacillus licheniformis are widely used in shrimp aquaculture to 
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provide beneficial effects potentially including improved health and water quality, 
control of pathogenic bacteria and their virulence, stimulation of the immune 
system and improved growth [11]. With the understanding that the use of 
antibiotics in large-scale aquaculture leads to the development and transfer of 
antibiotic resistance, investigation of probiotic approaches for the prevention of 
infectious disease has become important. For example, D’Alvise et al [12] have 
demonstrated that Phaeobacter gallaeciensis can be used as a probiotic treatment 
to reduce the density of the fish pathogen Vibrio anguillarum in cultures of cod 
larvae, resulting in the reduction of mortality by vibriosis in the cod larvae. The 
probiotic activity was dependent upon the production of tropodithietic acid (TDA) 
by P. gallaeciensis. Further, D’Alvise et al [13] previously demonstrated that a 
different TDA-producing strain of Phaeobacter was able to reduce or eliminate V. 
anguillarum from a combined liquid-surface system. These and other studies 
strongly suggest that antagonistic interactions by probiotic bacteria against marine 
pathogens may be useful in protecting commercially important species of shellfish 
and finfish from infectious disease. 
Phaeobacter gallaeciensis are gram-negative -Proteobacteria from the 
Roseobacter clade. The Roseobacter clade, an important member of the marine 
microbiota, accounts for ~5% to as much as ~40% of bacterial DNA from the 
ocean and plays an important role in the organic sulfur cycle of the ocean [14,15]. 
As noted above, several species in this clade have been shown to produce TDA and 
to exhibit inhibitory activity against the growth of marine pathogens, including V. 
anguillarum, V. tubiashii and R. crassostreae [16]. Additionally, many of these 
species from Roseobacter clade are routinely isolated from alga or larval cultures 
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of marine fish and shellfish [17]. Further, Phaeobacter species are typically 
excellent biofilm formers, colonizing a variety of surfaces including the walls of 
rearing tanks, microalgae, the skin of finfish, and the shells of mollusks [13,18,19]. 
Biofilm formation is thought to be essential for probiotic activity by a variety of 
mechanisms including competition for adhesion sites, oxygen, nutrients, and by 
preventing contact between pathogens and hosts [20]. 
Previously, we isolated P. gallaeciensis S4 from the inner shell surface of a 
healthy oyster [16]. This bacterium is a short rod with 1-2 flagella on one or both 
poles [16]. It has pleiomorphic morphology and will elongate into long rods and 
filaments under specific conditions (low salt concentration, static incubation, 
stationary phase [16]). It can form rosettes and is an excellent biofilm former and a 
dominant colonizer of surfaces in marine environments [16]. P. gallaeciensis 
S4Sm is a spontaneous streptomycin-resistant mutant of the parental S4 [16]. 
When S4Sm was used as a potential probiotic treatment of oyster larvae, it showed 
strong anti-pathogen activity and increased host survival. S4Sm can be used to 
antagonize diseases, but little is known about the actual mechanisms of action of 
this and other probiotic species [16].  
In this study we examine the roles of biofilm formation and TDA production 
in probiotic activity of P. gallaeciensis S4Sm on oyster challenged by marine 
pathogen, V. tubiashii. In order to determine the contributions of TDA production 
and biofilm formation to the probiotic activity of S4Sm, mutations in clpX (a 
regulator of TDA biosynthesis pathway [21]) and an exopolysaccharide 
biosynthesis gene (exoP) were created by insertional mutagenesis. The effects of 
these mutations upon TDA production, biofilm formation and probiotic activity 
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were determined.  
Materials and Methods 
Bacterial strains, plasmids, and growth conditions 
All bacterial strains and plasmids used in this report are listed in Table 1. P. 
gallaeciensis strains were routinely grown in yeast extract (0.5%)-peptone (0.1%) 
broth plus 3% sea salts, pH7.6 (YP30) [16], supplemented with the appropriate 
antibiotic, in a shaking water bath at 27°C. Overnight cultures of P. gallaeciensis, 
grown in YP30, were harvested by centrifugation (8,000 × g, 2 min) and the 
pelleted cells were washed twice with nine-salt solution (NSS) [22]. Washed cells 
were resuspended to appropriate cell densities in experimental media. Cell 
densities were estimated by optical density at 600 nm (OD600) and more accurately 
determined by serial dilution and spot plating. Specific conditions for each 
experiment are described in the text. Escherichia coli strains were routinely grown 
in Luria-Bertani broth plus 1% NaCl (LB10) [23]. Vibrio anguillarum strains were 
routinely grown in LB20 at 27°C [24]. V. tubiashii and R. crassostreae strains 
were routinely grown in YP30 at 27°C [16]. Antibiotics were used at the following 
concentrations: streptomycin, 200 μg/ml (Sm200); ampicillin, 100 μg/ml (Ap100) for 
E. coli and Vibrio strains; chloramphenicol, 20 μg/ml (Cm20) for E. coli and 5 
μg/ml (Cm5) for P. gallaeciensis and Vibrio strains; kanamycin, 50 μg/ml (Km50) 
for E. coli strains and 200 μg/ml (Km200) for P. gallaeciensis; and tetracycline, 15 
μg/ml (Tc15) for E. coli and 1 μg/ml (Tc1) for V. anguillarum. 
Insertional mutagenesis 
Insertional mutagenesis by homologous recombination was used to create 
 70 
interruptions within specific genes using a modification of the procedure described 
by Milton and Wolf-Watz [25,26]. Primers (Table 2) were designed to amplify 
specific Phaeobacter genes based on homologous sequences from P. gallaeciensis 
2.10 (GenBank accession No.CP002972.1). A fragment of the selected gene was 
PCR amplified, then digested with SacI and XbaI restriction enzymes, and the 
DNA fragments separated on a 1% agarose gel. Subsequently, the gel-purified 
PCR fragment was ligated into the suicide vector pNQ705 after digestion with SacI 
and XbaI and the ligation mixture was introduced into E. coli Sm10 (λ pir) by 
electroporation with Bio-Rad Gene Pulser II. The resulting recombinant plasmids 
were confirmed by both PCR amplification and sequencing. The mobilizable 
suicide vector was transferred from E. coli Sm10 (λ pir) into S4Sm by conjugation. 
Transconjugants were selected by utilizing the chloramphenicol resistance gene 
located on the suicide plasmid. The incorporation of the suicide vector into the 
gene of interest was confirmed by PCR analysis and DNA sequencing. 
Complementation of mutants 
P. gallaeciensis mutants were complemented by cloning the appropriate gene 
fragment into the shuttle vector pBBR1MCS4 (GenBank accession No. U25060), 
using a modification of the method described previously by Rock and Nelson [27]. 
Primers (Table 2) were designed with a SacI or XbaI site added to the 5’ end of the 
appropriate primer. The primer pair was then used to amplify the entire gene plus 
∼500 bp of the 5′ and 3′ flanking regions from genomic DNA sequences of P. 
gallaeciensis 2.10 (GenBank accession No.CP002972.1). The resulting amplicon 
was ligated into the pBBR1MCS4 plasmid after digestion with SacI and XbaI and 
the ligation mixture introduced into E. coli Sm10 (λ pir) by electroporation with 
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Bio-Rad Gene Pulser II. Transformants were selected on LB10-Amp100 agar 
plates and the recombinant plasmids confirmed by both PCR amplification and 
sequencing. The complementing plasmid, pBBR1MCS4-clpX or 
pBBR1MCS4-exoP, was transferred from E. coli Sm10 into clpX or exoP mutants 
by conjugation using the procedures described previously. The transconjugants 
were confirmed by PCR amplification. 
Fluorescence tagging of P. gallaeciensis strains and Vibrio species 
P. gallaeciensis strains were tagged by pRhokHi-2-OFP and V. tubiashii was 
tagged by pRhokHi-2-GFP. The orange fluorescence protein gene (ofp) and the 
green fluorescence protein gene (gfp) were PCR amplified by using the appropriate 
primer pair (Table 2) designed according to the sequence of pmOrange vector 
(Clontech, Cat. No. 632529) and pSUP202p/PflaB-gfp vector. The PCR product 
was digested with NdeI and BamHI restriction enzymes and the DNA fragments 
separated on a 1% agarose gel. Subsequently, the gel-purified ofp or gfp PCR 
fragment was ligated into pRhokHi-2 after digestion with NdeI and BamHI and the 
ligation mixture was introduced into E. coli Sm10 (λpir) by electroporation with 
Bio-Rad Gene Pulser II. Transformants were selected on LB10-Cm20 agar plates. 
The resulting plasmids, pRhokHi-2-OFP or pRhokHi-2-GFP, were transferred 
from E. coli Sm10 into S4Sm, clpX and exoP mutants or V. tubiashii and R. 
crassostreae by conjugation using the procedures described previously. 
pSUP202p/PflaB-gfp was transferred from E. coli Sm10 into V. anguillarum by 
conjugation using the procedures described previously [28]. The transconjugants 
were confirmed by fluorescence microscopy. 
TDA purification, identification and detection. 
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P. gallaeciensis S4Sm was cultured in 7 x 1 L volumes of YP30 culture 
medium at 27°C with shaking at 175 rpm. After 96 h, the cells were pelleted by 
centrifugation at 10,000 rpm for 10 min. The resulting culture supernatants were 
acidified to pH 3 with formic acid (FA) and extracted with acidified (0.1% FA) 
ethyl acetate. The organic extract was concentrated in vacuo to yield 0.673 g of 
crude extract. The extract was fractionated using C18 flash chromatography 
(Redisep Rf high performance gold 30g hp combiflash column; linear gradient 
elution 5% - 100% CH3OH in H2O, 0.1% FA, 35 ml/min, 45 min). Fractions 
containing TDA (tR= 15 min) were further purified by reversed-phased HPLC 
(Xterra 5µm C18 100 x 3.0 mm column, 0.5 ml/min, 5% to 100% CH3OHin H2O 
over 24 min). Pure TDA (10 mg) was identified based on comparison of 1H NMR 
(Varian 500 MHz spectrometer) and mass spectral data in comparison to 
previously reported values [29]. 
Culture supernatants from various P. gallaeciensis strains were analyzed by 
HPLC for the presence of TDA. P. gallaeciensis strains were cultivated in 50 ml 
YP30 broth until stationary phase (OD600 = 0.8). Cells were pelleted by 
centrifugation at 5000 ×g for 10 min, and the resulting supernatant was acidified to 
pH3 with FA and then partitioned with acidified ethyl acetate (0.1% FA). The 
organic layer was concentrated to dryness in vacuo and then reconstituted as a 
10mg/ml solution in methanol (Pharmco-AAPER). HPLC chromatography was 
performed on a Hitachi LaChromUltra UHPLC equipped with a Fortis C18 
UHPLC Column (1.7 µm, 2.1 x 50 mm). Method: 0.25 ml/min flow rate, 5% 
methanol in H2O (both acidified with 0.1% FA) for 1 min, linear gradient to 100% 
CH3OH over 6.2 min, 100% CH3OH for 2 min. 
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Minimum inhibitory concentrations of TDA against V. anguillarum, V. 
tubiashii, and R. crassostreae 
The minimal inhibitory concentrations (MIC) of TDA against the marine 
pathogens were determined using a broth dilution method in microtiter plates [30]. 
Overnight bacterial cultures were diluted to 105 CFU/ml in YP30 and treated with 
serial dilutions of pure TDA. After 24 h incubation, MICs were determined as the 
lowest concentration where there was no visible growth. Two independent 
experiments were done and each independent experiment had three replicates. 
Biofilm formation 
Bioﬁlm formation was assessed using a modification of the crystal violet (CV) 
staining method [19]. Bacteria were grown for 2 days in YP30 (27°C with shaking) 
to an cell density ~ 2  109 CFU/ml (2 l; 0.1% inoculum) were transferred into 2 
ml of fresh YP30 broth in 30 mm  100 mm borosilicate (Pyrex) glass culture 
tubes containing 2 ml of YP30 broth and allowed to grow at 27°C without shaking. 
When sampling, the liquid culture was discarded and each tube rinsed twice with 
NSS to remove loosely attached cells. The bioﬁlm attached to the test tube wall 
was stained with 2 ml of CV solution (0.2%) for 20 min at room temperature. 
Unbound dye was removed with two washes of NSS. The bound dye was eluted 
with 95% (vol/vol) ethanol for 30 min and then the amount of eluted crystal violet 
was measured by spectroscopy at 580 nm using a VERSA-MAX microplate 
reader. 
Inhibition zone assay  
Anti-bacterial activity of P. gallaeciensis strains was measured by a growth 
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inhibition assay using V. anguillarum, V. tubiashii, and R. crassostreae as the 
target organisms. Briefly, an aliquot (100 μl) from a stationary phase overnight 
culture of the appropriate Vibrio or R. crassostreae culture was spread onto YP30 
agar plates, then 10 μl of a 2-day-old culture (OD600 = 0.8) of a P. gallaeciensis 
strain was spotted in triplicate onto the pathogen cell lawn. After incubation at 
27°C for 24 h, the level of antibacterial activity was determined by the diameter of 
the inhibition zone around the P. gallaeciensis colonies. 
P. gallaeciensis culture supernatant killing assay 
In order to determine the bactericidal activity of culture supernatants, P. 
gallaeciensis strains were grown for 2 days in YP30 (27°C with shaking). Cultures 
were centrifuged (8,000 × g, 10 min) and filtered through 0.2 m pore membrane 
filters to collect filter sterilized cell-free supernatants. Overnight cultures of V. 
anguillarum (NB10Sm) cells were then serially diluted in filter sterilized, cell-free 
P. gallaeciensis culture supernatant obtained from the various strains of P. 
gallaeciensis or NSS, and then spotted (10 l/spot of diluted V. anguillarum cells) 
in triplicate onto YP30 plates. The time of exposure to S4Sm supernatant was 
during serial dilution (<5min) followed by time on plate with diffusion of TDA. 
Killing percentage was calculated as follows: Killing % = [(no. of colonies in NSS 
control) – (no. of colonies in S4 supernatant treated)/ (no. of colonies in NSS 
control)] × 100 
Glass coverslip colonization competition assay between P. gallaeciensis strains 
and V. tubiashii WZ103 or V. anguillarum WZ203. 
For all competition experiments, P. gallaeciensis strains (S4Sm, clpX mutant 
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and exoP mutant) were grown for 2 days in YP30 (27°C with shaking) to an OD600 
~0.8. Cells were harvested by centrifugation, washed twice in NSS, resuspended in 
fresh YP30, and then transferred into 6-well plates (Costar 3516). Each well 
contained a glass coverslip, 4 ml YP30 broth supplemented with the appropriate 
antibiotics, and was inoculated with the appropriate P. gallaeciensis strain tagged 
with orange fluorescence protein (OFP) (final concentration ~1×104 CFU/ml). For 
experiments examining the effects of pretreatment with P. gallaeciensis, after 24 h 
incubation at 27°C with no shaking (pretreatment with P. gallaeciensis) all 
coverslips were washed twice with NSS. Each coverslip was transferred into a 
fresh well containing 4 ml of YP30 broth supplemented with the appropriate 
antibiotic plus the green fluorescence protein (GFP)-tagged V. tubiashii WZ103 or 
GFP-tagged V. anguillarum WZ203 (final concentration ~1×105 CFU/ml). After 
another 24 h incubation at 27°C with no shaking, all coverslips were removed, 
washed twice on a rotary shaker (LAB-LINE instrument, Inc.) for 2 min (200 rpm) 
with NSS, and then transferred into clean wells with fresh YP30 broth and allowed 
to incubate as before. Two coverslips were removed at each sampling time (24, 48, 
72 h). One was used for determination of the cell density of the strains on the 
coverslip; the second one was used for confocal imaging. Glass coverslips were 
washed with NSS twice on a rotary shaker for 2 min. After draining excess water, 
coverslips used for confocal imaging were placed on depression slides and cells on 
the upside of coverslip were wiped off with Kimwipes. Coverslips used for CFU 
determinations were immersed in 50 ml plastic tubes containing 10 ml NSS and 
glass beads (0.5 g, 1 mm), then vortexed for 1 minute. Cell densities (CFU/ml) in 
the wells or suspended from the coverslip were determined by serial dilution and 
spot plating. For experiments without pretreatment with P. gallaeciensis, all 
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procedures were identical to those described above except that GFP-tagged V. 
tubiashii WZ103 or V. anguillarum WZ203 were added at the same time as 
OFP-tagged P. gallaeciensis. Additionally, in the V. anguillarum competition 
experiments, both P. gallaeciensis and V. anguillarum were inoculated at ~106 
CFU/ml. 
Effects of TDA supplementation on pathogen growth in a co-culture system 
containing the clpX mutant and a Vibrio species.  
OFP-tagged P. gallaeciensis strains (S4Sm, clpX mutant) grown for 2 days in 
YP30 (27°C with shaking) to an OD600 ~0.8, cells were transferred into 6-well 
plates (Costar 3516). Each well was inoculated with the appropriate OFP-tagged P. 
gallaeciensis strain (initial concentration at ~ 104 CFU/ml) and contained 4 ml of 
YP30 broth supplemented with the appropriate antibiotic and one glass coverslip. 
After 24 h incubation (pre-treatment with P. gallaeciensis), all coverslips were 
washed twice in NSS. Each coverslip was transferred into a clean well containing 4 
ml YP30 broth and either GFP-tagged V. anguillarum WZ203 or V. tubiashii 
WZ103 at a concentration of ~ 105 CFU/ml plus TDA (5 μg/ml for V. anguillarum 
WZ203 or 10 μg/ml for V. tubiashii WZ103; based on calculated MIC). The 
biofilms on the coverslips were imaged as described below and cell densities were 
determined as described above. 
Laser confocal scanning microscopy 
Laser confocal scanning microscopy was performed in the Rhode Island 
Genomic Sequencing Center using Zeiss LSM 700 laser scanning confocal 
imaging system and Zeiss Axio Imager 2 microscope.  
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Challenge trial 
Oyster larvae (n=21-28 per well, veliger stage, ~0.060-0.150 mm in diameter) 
were placed in wells of a 6-well plate containing 5 ml of sterile filtered seawater 
(28 psu). P. gallaeciensis strains were added to a concentration of ~104 CFU/ml. 
Plates were incubated at 20°C for 24 h with shaking. Water was changed and V. 
tubiashii RE22 was added at a concentration of ~105 CFU/ml and incubated for an 
additional 24 h before counting living and dead oysters. Oyster larvae treated only 
by artificial seawater serve as control (mock). The survival rate was calculated by 
using the formula: Survival rate (%) = 100 x (number of live larvae/total number 
of larvae). These experiments were run at least 2 times in triplicate [16]. As 
invertebrates, oysters are exempt from approval from IACUC. 
Statistical analysis 
Data statistical analysis was performed using SPSS v16.0 with general linear 
model (univariate or multivariate) for Windows and P<0.05 was considered to 
indicate a statistically significant difference. 
Results 
P. gallaeciensis S4Sm secretes the antibiotic tropodithietic acid. 
Bioassay-guided fractionation of P. gallaeciensis supernatants resulted in the 
purification of a single secondary metabolite possessing antimicrobial activity. The 
molecule was identified as tropodithietic acid (TDA) based upon a molecular ion 
of [M+H]+ = 211 [14] and comparison of 1H NMR chemical shift data (500 MHz, 
C6D6) with literature values (not shown). UHPLC analysis data (Fig. 1A) 
confirmed that TDA was present in S4Sm supernatant. 
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Biofilm formation by P. gallaeciensis S4Sm.  
It was previously reported that Phaeobacter spp. are effective surface 
colonizers [13,17]. Using the crystal violet staining assay [19] to determine biofilm 
formation ability of S4Sm, we observed that S4Sm formed thick biofilms on glass. 
In this assay, the OD580 value for the S4Sm biofilm after 60 h was ~4.0 at 27C 
under static conditions (Table 3). In contrast, all three pathogens (V. anguillarum, 
V. tubiashii, and R. crassostreae) used in this study had biofilms that were between 
13.4-14.9% of the S4Sm (Table3) (P< 0.05).These data suggested that S4Sm was 
able to form a thick, dense biofilm matrix on glass coverslips and tubes. 
 
Differential sensitivities of marine pathogens to TDA.  
It was previously reported that Phaeobacter species antagonized and killed 
the fish pathogen V. anguillarum [13,17]. Since we had previously shown that P. 
gallaeciensis S4 was able to protect oyster larvae against mortalities caused by V. 
tubiashii and R. crassostreae [16], we examined the relative sensitivities of the 
three pathogens (V. anguillarum NB10Sm, V. tubiashii RE22Sm, and R. 
crassostreae CV919Sm) to P. gallaeciensis S4Sm (a spontaneous 
streptomycin-resistant mutant of S4) by looking at the inhibition of growth around 
a colony of S4Sm. V. anguillarum NB10Sm was most sensitive to S4Sm with 
largest zone of inhibition (ZOI) (diameter = 12.5±0.5 mm); R. crassostreae 
exhibited slightly less sensitivity to S4Sm (ZOI =11.2±0.3 mm); and the least 
sensitive pathogen to S4Sm was V. tubiashii RE22Sm (ZOI = 9.2±0.6 mm) (Fig. 
1C) These data corresponded with the results for minimum inhibitory 
concentration (MIC) of TDA against each of the three pathogens: the MIC for 
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TDA against NB10Sm was 1.25 μg/ml, against R. crassostreae the MIC was 5 
μg/ml, and against RE22Sm the MIC was 6.25 μg/ml.  
Effect of clpX gene mutation on TDA production. 
In order to examine the roles of TDA production and biofilm formation in the 
probiotic activity of S4, we performed mutations on genes involved in the TDA 
biosynthesis pathway. Our data showed that tdaA, tdaB, and tdbD mutants not only 
lost TDA production, but were also defective for biofilm formation (Fig. S1). In 
order to examine the separate roles of TDA production and biofilm formation with 
respect to probiotic activity, we needed mutants that were deficient in either TDA 
synthesis or biofilm production. It was previously shown that mutation in clpX by 
transposon mutagenesis resulted in the loss of TDA production in Phaeobacter sp. 
strain 27-4 [21]. The clpX gene was identified in S4Sm and found to encode a 408 
amino acid ATP-dependent protease ATP-binding subunit and is part of the ClpXP 
multimer. Mutation of clpX by insertional mutagenesis resulted in the loss of TDA 
production. UHPLC analysis data (Fig. 1B) showed that no TDA was present in 
clpX mutant supernatant. Further, there were no inhibition zones around the clpX 
mutant cells when tested against the three pathogens, V. anguillarum NB10Sm, V. 
tubiashii RE22Sm, and R. crassostreae CV919Sm (Fig. 1C). Additionally, culture 
supernatant from the clpX mutant was no longer able to kill NB10Sm cells (Table 
4). Complementation of the clpX gene restored TDA production (Fig. 1B) and 
anti-Vibrio activity (Fig. 1C and Table 4). Mutation of clpX did not result in 
defective biofilm formation (Table 3). 
Effect of exoP gene mutation on biofilm formation  
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In order to develop a strain of S4 defective in biofilm formation but able to 
produce TDA, the exoP gene, which encodes an exopolysaccharide biosynthesis 
domain protein, was identified in P. gallaeciensis S4Sm strain. Mutation of exoP 
resulted in decreased biofilm formation, with the exoP mutant exhibiting only 25% 
to 50% of the wild type level (Table 3) (P < 0.05). Complementation of exoP gene 
restored biofilm formation to wild type level (Table 3). Mutation of exoP did not 
result in defective TDA production (Fig. 1B). 
Effect of clpX and exoP mutations on the ability of P. gallaeciensis to 
antagonize Vibrio species in a mixed culture colonization assay. 
The clpX mutant is characterized by the inability to produce TDA, but is able 
to form a normal biofilm, while the exoP mutant is characterized by its reduced 
ability to form a biofilm while producing TDA at wild type levels. This allowed us 
to examine the relative roles of biofilm formation and TDA production on the 
ability of S4 to antagonize colonization of glass surfaces by the pathogens used in 
this study, as well as decrease the levels of pathogen in the culture media. When a 
co-colonized glass coverslip was examined after 72 h of growth by laser scanning 
confocal microscopy, more RE22Sm cell clusters were observed in the biofilm 
matrix of the clpX mutant than in the biofilm matrix of either S4Sm wild type or 
exoP (Fig. 2A). These observations were reflected in the viable cell counts of the V. 
tubiashii RE22Sm in both biofilms (sessile) and in suspension (planktonic) when 
grown in the presence of biofilms of P. gallaeciensis S4Sm wild type, the clpX 
mutant or the exoP mutant (Fig 2B-E). For example, as shown in Fig 2B and 2C at 
123 h, the number of viable RE22Sm in the biofilm on a coverslip was 1×104 CFU 
when precolonized with S4Sm. In contrast, the number of RE22Sm cells increased 
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180-fold (to 1.8×106 CFU/coverslip) when grown in the presence of the clpX 
mutant. This was about the same number of cells on a coverslip as when RE22Sm 
was allowed to colonize alone. Further, when grown in the presence of the exoP 
mutant the number of viable RE22 cells was 4.5-fold higher (4.5×104 
CFU/coverslip) than in the presence of S4Sm cells. In suspension, the cell density 
of RE22Sm reached 2×108 CFU/ml under conditions of precolonization by the 
clpX mutant; this was similar to the density of RE22Sm grown alone (1.8 ×108 
CFU/ml), but about two orders of magnitude higher than when RE22Sm was 
co-cultured with either S4Sm (3.1 ×106 CFU/ml) or exoP (2.6 ×106 CFU/ml) (P < 
0.05) (Fig. 2E). These data indicated that the clpX mutant was not able to inhibit 
RE22Sm growth or biofilm formation under the tested conditions, while the exoP 
mutation had little effect on the ability to inhibit RE22Sm growth or biofilm 
formation. When the same experiments were performed using V. anguillarum 
NB10, the results were very similar. The wild type S4 almost completely 
eliminated NB10 from the coverslip and from suspension by 40 to 48 h, 
respectively (Fig. S2B-D). The exoP mutant inhibited NB10 biofilm formation and 
survival in suspension almost as well as S4Sm. In contrast, the clpX mutant (TDA 
deficient) exhibited almost no inhibition on either biofilm formation or survival of 
NB10, compared to the ones when NB10 grown alone. These observations are also 
illustrated by the confocal images of biofilms formed by OFP-tagged P. 
gallaeciensis strains and GFP-tagged NB10 cells (Fig. S2A).  
Addition of exogenous TDA restores the antagonistic activity of the clpX 
mutant. 
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The correlation between the loss of TDA production and that the clpX mutant 
was unable to block biofilm formation by any of the tested pathogens strongly 
suggested that the loss of TDA biosynthesis was responsible for the defect in 
antagonistic activity in the clpX mutant. In order to confirm the hypothesis, we 
repeated the coverslip colonization experiments with the addition of exogenous 
TDA. TDA (10 μg/ml) was added to the co-culture system at the same time as the 
pathogens; distilled water was added to the non-exogenous-TDA control group. As 
expected, 24 h after RE22Sm addition, the amount of RE22 in the biofilm formed 
by both RE22 and WZ10 (clpX mutant) was significantly (15-fold) higher than 
RE22Sm co-cultured with S4Sm (1.8×106±4×105CFU/coverslip 
vs1.2×105±3.5×104 CFU/coverslip, P=0.019) (Fig. 3A) in the non-exogenous-TDA 
group. However, when the cultures were supplemented with 10 μg/ml of 
exogenous TDA, the amount of RE22Sm (at T=24 h) in the biofilm of RE22Sm 
and clpX mutant showed no significant difference from the amount of RE22Sm (at 
T=24 h) in the biofilm of RE22Sm and S4Sm (2.27×103±288 CFU/coverslip vs. 
1.37×103±321 CFU/coverslip, P = 0.099). Further, the amount of RE22Sm in the 
biofilm (at T=24 h) in a monoculture in the presence of TDA (1.5×103±600 
CFU/coverslip) (Fig. 3A) was not significantly different from the amounts found in 
either of the two TDA-treated mixed culture biofilms. Similar results were 
observed for planktonic RE22 cells in culture of the co-culture system (Fig. 3C).  
The effects of exogenous TDA were transitory. By 48 h after TDA addition, 
amounts of sessile RE22Sm cells, which was co-cultured with clpX mutant, 
increased nearly two log units (24 h vs. 48 h, 2.27×103±288 CFU/coverslip vs. 
3.67×105±1.53×105 CFU/coverslip). However, amount of sessile RE22Sm, which 
was co-cultured with S4Sm, only exhibited ~2.3-fold increase from 1.37×103±321 
 83 
CFU/coverslip (24 h) to 3.13×103±1.07×103CFU/coverslip (48 h). Additionally, at 
48 h the amounts of RE22Sm cells in both the biofilm and in suspension, which 
were co-cultured with the clpX mutant, were not significantly different with the 
values for RE22Sm cultured alone (Fig. 3A and C). Further, the confocal 
micrographic images of biofilms from 48 h cultures confirmed that more RE22Sm 
cells (green) were observed in the clpX mutant biofilm than in S4Sm biofilm (Fig. 
3B). The explanation for the transient effect of exogenous TDA upon RE22Sm 
cells could be that TDA is unstable over the period of the assay. Taken together, 
our data strongly suggest that the loss of TDA biosynthesis is responsible for the 
defect in antagonistic activity in the clpX mutant. 
The effects of V. tubiashii on growth of P. gallaeciensis strains in competition 
assays. 
Our study showed that P. gallaeciensis strains (S4Sm wild type, clpX or exoP 
mutants) exhibited different inhibitory effects against V. tubiashii in competition 
assays. In order to see if V. tubiashii would affect the growth of our various P. 
gallaeciensis strains, we compared the growth of P. gallaeciensis strains in the 
presence of V. tubiashii with monoculture controls. The growth of wild type S4Sm 
and exoP mutant were not affected by V. tubiashii in either suspension or on the 
coverslip (Fig. 4). In contrast, the growth of the clpX mutant was affected by V. 
tubiashii. At each time point tested, the density of the clpX mutant (grown with 
RE22Sm) was lower than that of the monoculture control (Fig. 4). For example, at 
72 h the biofilm density of clpX mutant cells grown in the presence of RE22 was 
13.2% of clpX mutant cells grown axenically (3.3×106±5.3×105 CFU/coverslip vs. 
2.5×107±1.2×106 CFU/coverslip, P< 0.05).  Similarly, the planktonic cell density 
of clpX mutant cells grown in the presence of RE22 was 13.5% of clpX mutant 
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cells grown axenically (3.1×107±6.0×106 CFU/ml vs. 2.3×108±6.9×107 CFU/ml, 
P< 0.05). These data suggest that P. gallaeciensis clpX mutant was affected 
differently by V. tubiashii when co-cultured; however, the wild type S4Sm and 
exoP mutant were not affected by co-culture with V. tubiashii. Additionally, when 
V. anguillarum NB10Sm was co-cultured with either S4Sm or the exoP mutant, it 
did not affect their growth; however, NB10Sm did inhibit the growth of the clpX 
(Fig. S3).  
Pre-colonization of Phaeobacter is important for probiotic activity of S4Sm 
against V. tubiashii in vitro. 
Karim et al. [16] and D’ Alvise et al. [12] showed that pretreatment with 
probiotic Phaeobacter species protected oyster and cod larvae, respectively, from 
infections caused by pathogenic bacteria. In order to determine if pre-colonization 
was important for the probiotic/antagonistic activity of P. gallaeciensis S4Sm 
against Vibrio pathogens, the effects of a 24 h pre-colonization by the probiont 
followed by addition of the pathogen were tested (Fig. 5). On the coverslip, the 
amount of RE22Sm cells in the biofilm (without pre-colonization:RE22Sm and 
S4Sm were introduced into system at the same time) was ~8.3×107 CFU/coverslip 
at 48h (Fig. 5A). This was 830-fold more RE22 cells than the one detected in the 
biofilm of a coverslip, which was pre-colonized with S4 (1×104 CFU/coverslip) 
(Fig. 2B). Similarly, without pre-colonization by the P. gallaeciensis mutants (clpX 
or exoP mutants) RE22Sm exhibited 10- to 100-fold more cells in the mixed 
biofilm compared to biofilms formed with pre-colonization by the P. gallaeciensis 
mutants (for exoP: the amount of RE22Sm with pre-colonization is ~1×105 
CFU/coverslip, without pre-colonization ~1.1×107 CFU/coverslip; for clpX: with 
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pre-colonization~1.2×106 CFU/coverslip, without pre-colonization~1.05×107 
CFU/coverslip) (Fig. 2B, Fig. 5A). Further, as shown above, in experiments where 
S4Sm was allowed to pre-colonize coverslips the density of planktonic RE22Sm 
cells (~2.8×107 CFU/ml) was only 8.7% of the density of plankton S4Sm cells 
(3.2×108 CFU/ml) in the same co-culture system at 48h (Fig. 2D); however, 
without pre-colonization, cell density of planktonic RE22Sm (at 48 h) was~ 
9.3×108 CFU/ml. This was >30-fold higher than the density of RE22Sm observed 
in the pre-colonized culture (2.8×107 CFU/ml). This was also 66-fold higher than 
the growth of S4Sm (1.4×107 CFU/ml) in the same co-culture system (Fig. 5B). In 
contrast, pre-colonization with S4Sm was not necessary to antagonize V. 
anguillarum (NB10Sm). In experiments where S4Sm and NB10 were inoculated 
together, NB10Sm was eliminated from both the coverslip biofilm and the liquid 
culture by 48 h (Fig. S2). Further, NB10 was also more sensitive to both the exoP 
and clpX mutants than RE22 in the co-culture experiments. These data indicate that 
pre-colonization facilitated S4Sm inhibition of V. tubiashii RE22, but was not 
necessary for inhibition against V. anguillarum NB10. Further, the data also 
suggest that V. anguillarum NB10 is more sensitive to P. gallaeciensis S4Sm than 
is V. tubiashii RE22. 
Mutations in clpX and exoP affect probiotic activity of P. gallaeciensis against 
V. tubiashii in oyster larvae. 
It was reported previously that P. gallaeciensis was able to reduce V. 
anguillarum in cultures of microalgae and rotifers, and prevent vibriosis in cod 
larvae [12]. Also our previous study showed that S4Sm provided protection to 
oyster larvae against V. tubiashii RE22 [16]. In order to determine if mutations in 
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TDA production or biofilm formation would affect the probiotic activity of S4Sm 
against V. tubiashii in vivo, oyster challenge assays were performed and the 
survival of oyster larvae was determined (Fig. 6). P. gallaeciensis mutants showed 
a significant reduction in their ability to protect oysters against V. tubiashii 
challenge compared to wild type S4Sm. The clpX mutant exhibited a >50% decline 
in oyster larvae survival compared to S4Sm (S4Sm: 72.4% ± 1.4% vs. clpX: 35.7% 
± 3.3%, P< 0.05), while the exoP mutant provided almost 70% of the protection as 
S4Sm (S4Sm: 72.4% ± 1.4% vs. exoP: 50.6% ± 8.3 %, P<0.05) (Fig. 6). However, 
both P. gallaeciensis mutants still provided partial protection. Survival in larvae 
pretreated with either the clpX or exoP mutant (35.7% ± 3.3% and 50.6% ± 8.3%, 
respectively) was significantly higher than the survival of larvae treated only with 
RE22 (20.3% ± 1.9%, P < 0.05) (Fig. 6). These data show that both the clpX and 
exoP mutant exhibited decreased ability to protect oyster larvae against V. 
tubiashii.  
Discussion 
Several Phaeobacter species are known to have probiotic activity and are able 
to protect fish species against bacterial pathogens [12]. The production of the 
broad-spectrum antibiotic, tropodithietic acid (TDA) is regarded as one of the 
major factors contributing to probiotic activity [12]. We recently reported that the 
new isolate P. gallaeciensis S4Sm protects the Eastern oyster (Crassostrea 
virginica) from infection by two oyster pathogens, V. tubiashii and R. crassostreae 
[16]. In this report, we dissect the roles of TDA biosynthesis and biofilm formation 
in promoting probiotic activity by P. gallaeciensis S4Sm, showing that both 
mechanisms are involved. 
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Although the TDA biosynthetic pathway has not been fully elucidated, many 
of the genes required for the formation of TDA and much of the pathway have 
been discovered [21,31,32]. One gene reported to be involved in the regulation of 
TDA biosynthesis is clpX (encoding ClpX) [21]. ClpX is an AAA+ ATPase that 
functions as an unfoldase chaperon for ClpP (ATP-dependent protease) and with 
ClpP forms the multimeric ClpXP protease [33]. We created an insertional 
mutation in the clpX gene and this mutation specifically blocked the biosynthesis 
of TDA in S4Sm (Fig. 1A) without affecting biofilm formation. In contrast, 
mutations in tdaA, tdaB, and tdbD, all block TDA biosynthesis and also affect 
biofilm formation. The mechanism by which ClpX affects TDA production is still 
unknown. Additionally, the reasons why mutations in tdaA, tdaB, and tdbD 
decrease biofilm formation, as well as TDA biosynthesis, are not understood. 
The clpX mutant was unable to inhibit V. tubiashii growth in either liquid or 
as a biofilm on a glass coverslip (Fig. 2); however, when cultures were 
supplemented with TDA, V. tubiashii growth was inhibited (Fig. 3). These data 
strongly suggest that the loss of TDA production is responsible for the defect in 
antagonistic activity in the clpX mutant. Further, 48 h after the addition of TDA 
into the co-culture the inhibitory effect of TDA disappeared, likely due to 
instability of TDA over time. Except for the loss of TDA synthesis, the clpX 
mutant exhibits no other defects in growth or biofilm formation compared to the 
S4Sm wild type. Moreover, the results reported here confirm the role of TDA as an 
antibiotic promoting probiotic activity of Phaeobacter species described 
previously by D’Alvise et al [12]. 
P. gallaeciensis, a member of the abundant marine Roseobacter clade, is 
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known to be an excellent colonizer of environmental surfaces [31]. However, no 
study of the effects of biofilm formation on the probiotic mechanism of 
Phaeobacter has been reported. The exoP gene was identified in S4Sm (using 
RAST [34]) as an exopolysaccharide biosynthesis gene, which is thought to be 
involved in biofilm formation. Mutation in exoP results in a large decrease in 
biofilm formation (Table 3). While the exoP mutant is defective in its ability to 
inhibit Vibrio species in competition assays (Figs. 2 & 5) and also exhibits 
decreased probiotic activity in oyster challenge assay against V. tubiashii (Fig. 6), 
these declines are less than those seen in the clpX mutant. These data suggest that 
biofilm formation is important for S4Sm probiotic activity. Biofilms may 
contribute to probiotic activity in two ways. First, biofilms would allow P. 
gallaeciensis to physically occupy potential sites of colonization and prevent the 
oyster pathogens from gaining access to the oyster. Second, the formation of an 
extensive biofilm with cells at high density may induce the production of TDA. A 
more extensive biofilm would produce more TDA and, therefore, more effectively 
inhibit the ability of pathogens to infect the oyster host. It should also be noted that 
other than decreased biofilm formation, the exoP mutant exhibits no other defects 
in growth or TDA formation. 
As a broad spectrum antibiotic TDA inhibits the growth of several marine 
pathogens [35]. However, in the ocean environment TDA will be rapidly diluted 
once it is secreted. We suggest that P. gallaeciensis requires both TDA production 
and biofilm formation for effective probiotic activity. The biofilm matrix creates a 
micro-environment, within which TDA can accumulate, without rapid dilution by 
seawater, to reach concentrations high enough to inhibit pathogens. In the absence 
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of TDA, a P. gallaeciensis biofilm does not eliminate pathogens and provides only 
modest protection against disease. Further, P. gallaeciensis growing with a 
diminished biofilm also exhibits significantly reduced probiotic activity probably 
due to the decreased mass of cells producing TDA and the increase in available 
sites for pathogens to colonize. Our data indicate that maximum probiotic activity 
requires both TDA production and biofilm formation. 
Karim et al. [16] reported that oyster larvae were best protected when P. 
gallaeciensis S4Sm was added 24 h prior to challenge by either of the two oyster 
pathogens, V. tubiashii and R. crassostreae. The data presented in this report 
correspond with those previous observations and reveal that pre-colonization of a 
surface by S4Sm is most effective at inhibiting V. tubiashii RE22 from either 
colonizing the glass coverslip surface or from growing planktonically. The 
generation time of Vibrio species in YP30 is less than 1 hour (V. tubiashii is ~0.53 
h, V. anguillarum is ~0.89 h); however, the doubling time for P. gallaeciensis 
S4Sm is ~3.1 h. These observations suggest that successful probiotic activity by 
S4Sm is also dependent upon growth rate and having enough TDA producing cells 
in the biofilm to successfully antagonize and out-compete the oyster pathogens. 
Practically, this means that it is necessary for oysters to be pretreated with P. 
gallaeciensis S4Sm prior to challenge by potential oyster pathogens, such as V. 
tubiashii and R. crassostreae. In contrast, D’ Alvise et al. [12] showed that it was 
not necessary for P. gallaeciensis to precolonize the wells containing cod larvae in 
order to antagonize V. anguillarum and significantly reduce cod larvae mortalities. 
However, they added 10-fold more P. gallaeciensis cells (107 CFU/ml) than V. 
anguillarum cells (106 CFU/ml) and V. anguillarum is more sensitive to TDA than 
 90 
is V. tubiashii. Further, this density of P. gallaeciensis is 103-fold higher than the 
density used in our experiments reported here and previously by Karim et al [16] .  
Additionally, we used 10-fold more V. tubiashii (105 CFU/ml) than P. 
gallaeciensis (104 CFU/ml). This suggests that cell density and, ultimately for P. 
gallaeciensis, biofilm formation contributes to probiotic activity.  
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Table 1. Bacterial strains and plasmids used in this study. 
Strains or 
plasmids 
Description Resistance Reference 
P. gallaeciensis    
S4 
Previously Phaeobacter sp. S4; wild 
type isolate from the inner shell of 
oysters 
 
Karim et al, 
2013 
S4Sm Spontaneous Smr mutant of S4 Smr this study 
WZ10 clpX insertional mutant of S4Sm Smr Cmr this study 
WZ11 
clpX+, clpX in trans complement of 
WZ10 
Smr Cmr Apr this study 
WZ20 exoP insertional mutant of S4Sm Smr Cmr this study 
WZ21 
exoP+, exoP in trans complement of 
WZ20 
Smr Cmr Apr this study 
WZ02 S4Sm (pRhokHi-2-ofp) Smr Cmr Kmr this study 
WZ12 clpX, WZ10 (pRhokHi-2-ofp) Smr Cmr Kmr this study 
WZ22 exoP, WZ20 (pRhokHi-2-ofp) Smr Cmr Kmr this study 
V. tubiashii    
RE22 Wild type isolate from oyster larvae  
Estes et al, 
2004 
RE22Sm Spontaneous Smr mutant of RE22 Smr this study 
WZ103 RE22Sm (pRhokHi-2-gfp) Smr Apr this study 
V. anguillarum    
NB10 
Wild type, serotype O1, clinical 
isolate from the Gulf of Bothnia 
 
Norqvist et 
al, 1989 
NB10Sm Spontaneous Smr mutant of NB10 Smr this study 
WZ203 NB10Sm (pSUP202P-PflaB-gfp) Smr Apr Tetr this study 
R. crassostreae    
CV919-312T 
Wild type isolate from a JOD-affected 
oyster 
 
Boettcher et 
al, 1999 
CV919Sm 
Spontaneous Smr mutant of 
CV919-312T 
Smr this study 
E. coli    
Sm10 
thi thr leu tonA lacY supE recA RP4-2 
Tc::Mu::Km (λpir) 
Kmr 
Simon et al, 
1983 
S100 Sm10 harboring pNQ705-1  this study 
WQ10 Sm10 harboring pNQ705-clpX  this study 
WQ20 Sm10 harboring pNQ705-exoP  this study 
WB01 Sm10 harboring pBBR1MCS4  this study 
WB11 Sm10 harboring pBBR1MCS4-clpX  this study 
WB21 Sm10 harboring pBBR1MCS4-exoP  this study 
S122 Sm10 harboring pSUP202P-gfp(ORF)  this study 
S136 Sm10 harboring pSUP202P-PflaB-gfp  this study 
W900 Sm10 harboring pRhokHi-2-FbFP  this study 
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WR03 Sm10 harboring pRhokHi-2-gfp  this study 
WR02 Sm10 harboring pRhokHi-2-ofp  this study 
W901 Sm10 harboring pmOrange  this study 
Plasmids    
pNQ705-1 Cmr; suicide vector with R6K origin  
Mcgee, 
1996 
pNQ705-clpX 
Cmr; derivative from pNQ705-1 for 
clpX insertional mutant 
 this study 
pNQ705-exoP 
Cmr; derivative from pNQ705-1 for 
exoP insertional mutant 
 this study 
pBBR1MCS4 
Apr; derivative from pBBR1MCS (a 
broad-host-range cloning vector) 
 
Kovach et 
al, 1995 
pBBR1MCS4-clp
X 
Apr; derivative from pBBR1MCS4 
for clpX in trans complement 
 this study 
pBBR1MCS4-exo
P 
Apr; derivative from pBBR1MCS4 
for exoP in trans complement 
 this study 
pBS(gfp)-Pcampy 
Template for gfp ORF PCR 
amplification 
 
Eggers et al, 
2004 
pCE320(gfp)-Pfla
B 
Template for PflaB PCR amplification  
Eggers et al, 
2004 
pSUP202P Apr Cmr Tcr; broad host shuttle vector  
Simon et al, 
1983 
pSUP202P-gfp(O
RF) 
Apr Tcr; derivative from pSUP202 for 
GFP tagging 
 this study 
pSUP202P-PflaB-
gfp 
Apr Tcr; derivative from pSUP202 for 
GFP tagging 
 this study 
pRhokHi-2-FbFP 
Cmr Kmr; derivative from 
pBBR1MCS (a broad-host-range 
cloning vector) with promoter PaphII 
 
Piekarski et 
al, 2009 
pRhokHi-2-gfp 
Cmr Kmr; derivative from 
pRhokHi-2-FbFP with gfp under the 
control of PaphII 
 this study 
pmOrange 
Template for ofp ORF PCR 
amplification 
 
Clontech 
Laboratorie
s, Inc. 
pRhokHi-2-ofp 
CmrKmr; derivative from 
pRhokHi-2-FbFP with ofp under the 
control of PaphII 
 this study 
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Table 2. Primers used in this study 
Primer 
Sequence (5' to 3', underlined 
sequences are engineered restriction 
sites) 
Description 
pw108 
GAAGAGCTCGGACGACTATGTGA
TTGGTCAGGC 
For clpX insertional mutation, 
forward, with SacI site 
pw109 
GGGTCTAGACGACGTTATATTCCG
ACGCCTGCA 
For clpX insertional mutation, 
reverse, with XbaI site 
pw153 
GTATTAGAGCTCGAGCATAACCGC
TTTGCCCGCCGCCCA 
For exoP insertional mutation, 
forward, with SacI site 
pw154 
CGACTATCTAGACCATGCTGAGTG
CAAGGTTGACGGCGG 
For exoP insertional mutation, 
reverse, with XbaI site 
pw127 
GCATTAGAGCTCGTCAGATTGGCC
GAAGCCCCTTTT  
For clpX in trans complement, 
forward, with SacI site 
pw128 
CGGCTATCTAGACGAACTCACCAC
CTGAGGAGATACGT 
For clpX in trans complement, 
reverse, with XbaI site 
pw166 
GTATTAGAGCTCCCCGTCCGATGT
GTCAAAATAGGT 
For exoP in trans complement, 
forward, with SacI site 
pw165 
CGTCTTTCTAGAGGTGCCTGCGGT
CATCACCATGAC 
For exoP in trans complement, 
reverse, with XbaI site 
pwGFP-F 
GCGGTACATATGTAAGGAGGAAA
AACATATG 
For amplification of gfp ORF, 
forward, with NdeI site 
pwGFP-R 
CTATATGGATCCCAGATCTATTTG
TATAGTTCATCCA 
For amplification of gfp ORF, 
reverse, with BamHI site 
Pm113 GGTACCTGTCTGTCGCCTCTTGT 
For amplification of PflaB, 
forward, with KpnI site 
Pm114 GGTACCATATCATTCCTCCATGAT 
For amplification of PflaB, 
forward, with KpnI site 
pwmO-F 
GCGGTACATATGATGGTGAGCAA
GGGCGAGGAGAAT 
For amplification of ofp ORF, 
forward, with NdeI site 
pwmO-R 
CTATATGGATCCCTTGTACAGCTC
GTCCATGCCGCC 
For amplification of ofp ORF, 
reverse, with BamHI site 
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Table 3. Quantification of biofilm formation by measuring OD580 of crystal violet 
dye attached to the cells forming biofilms on glass tubes at 27C under static 
condition at 60h. The data presented are average of two independent experiments 
and each independent experiment has three replicates.  
 
 
 
 
 
 
aBiofilm formation quantified by crystal violet dye assay as described in the 
Materials and Methods. The data presented are the average of two independent 
experiments and each independent experiment has three replicates.  
bStatistically significant difference compared to S4Sm. 
 
 
 
 
 
 
Strains OD580
a 
P. gallaeciensis S4Sm 3.89±0.06 
P. gallaeciensis WZ10 (clpX-) 3.90±0.12 
P. gallaeciensis WZ11 (clpX+) 4.0±0.06 
P. gallaeciensis WZ20 (exoP-) 1.60±0.09b 
P. gallaeciensis WZ21 (exoP+) 3.90±0.10 
V. anguillarum NB10Sm 0.58±0.02b 
V. tubiashii RE22Sm 0.54±0.02b 
R. crassostreae CV919Sm 0.52±0.08b 
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Table 4. Killing ability of culture supernatant of various P. gallaeciensis strains 
against V. anguillarum NB10Sm cell. Culture supernatant from each strain 
collected after two-day inoculation. The data presented is from a representative 
experiment of two independent experiments.  
Treatment 
Surviving V. anguillarum cell density 
(CFU/ml) after the treatment 
NSS (negative control) 40.67 (±3.79)×107 
S4Sm culture supernatant <10 
WZ10 (clpX-) culture supernatant 41.33 (±1.53)×107 
WZ11 (clpX+) culture supernatant <10 
WZ10 (clpX-) culture supernatant 
plus TDA 
<10 
WZ20 (exoP-) culture supernatant <10 
WZ21 (exoP+) culture supernatant <10 
 
Figure 1. A and B) Reversed-phase HPLC chromatograms of ethyl acetate extracts 
from Phaeobacter strains showing presence (A) or absence of TDA (B). C) 
Inhibition zone assay of S4Sm, clpX mutant (clpX), clpX complement (clpX+), 
exoP mutant (exoP) or exoP complement (exoP+) on YP30 plates coated by V. 
anguillarum (NB10Sm), V. tubiashii (RE22Sm) or Roseovarius crassostreae 
(CV919Sm) after 24 h at 27C. The data presented are averages of two 
independent experiments and each independent experiment has three replicates. 
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Figure 2. Competition assay between P. gallaeciensis strains and V. tubiashii with 
pre-colonization of glass surfaces by P. gallaeciensis for 24h. The mixed cultures 
are S4Sm-OFP with RE22Sm-GFP, clpX-OFP with RE22Sm-GFP and exoP-OFP 
with RE22Sm-GFP. A) Merged confocal microscopy images of mixed biofilm 
development by OFP-producing strains (S4Sm, clpX mutant and exoP mutant) and 
GFP-producing V. tubiashii (RE22Sm) strain on the surface of glass coverslip at 72 
h. The data presented are from a representative experiment of two independent 
experiments. B) Growth of sessile P. gallaeciensis and V. tubiashii (RE22Sm) in a 
co-culture system. C) Comparison of growth of sessile V. tubiashii (RE22Sm) in 
different co-culture systems and monoculture control. D) Growth of planktonic 
Phaeobacter cells and V. tubiashii (RE22Sm) in a co-culture system. E) 
Comparison of growth of planktonic V. tubiashii (RE22Sm) in different co-culture 
systems and monoculture control. The data presented are average of two 
independent experiments and each independent experiment has three replicates. 
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Figure 3. TDA supplementation in co-culture system between clpX mutant and V. 
tubiashii. A) Growth of sessile V. tubiashii on a glass coverslip in co-culture 
system (supplemented without or with 10μg/ml TDA) with different Phaeobacter 
strains. The data presented are average of two independent experiments and each 
independent experiment has three replicates. B) Single channel and merged 
confocal microscopy images of mixed biofilm development by OFP-producing 
strains (S4Sm, clpX mutant) and GFP-producing V. tubiashii (RE22Sm-GFP) on 
the surface of glass coverslip at 48 h after addition of RE22Sm and TDA. The data 
presented is from representative experiments of two independent experiments. C) 
Growth of planktonic V. tubiashii in co-culture system (supplemented without or 
with 10 μg/ml TDA) with different Phaeobacter strains. The data presented are 
averages of two independent experiments and each independent experiment has 
three replicates.  
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Figure 4. Effects of V. tubiashii on the growth of P. gallaeciensis strains in a 
competition assay with a 24 h pre-colonization by P. gallaeciensis. The mixed 
cultures are: S4Sm-OFP with RE22Sm-GFP, clpX-OFP with RE22Sm-GFP and 
exoP-OFP with RE22Sm-GFP. Colonization and initial cell densities were as 
described in the Materials and Methods. A) Growth of sessile P. gallaeciensis cells 
(with RE22Sm) in a co-culture system and a monoculture control. B) Growth of 
planktonic P. gallaeciensis cells (with RE22Sm) in a co-culture system and a 
monoculture control. The data presented are average of two independent 
experiments and each independent experiment has three replicates. 
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Figure 5. Competition assay between Phaeobacter strains and V. tubiashii without 
pre-colonization by Phaeobacter. The mixed cultures areS4Sm-OFP with 
RE22Sm-GFP, clpX-OFP with RE22Sm-GFP, and exoP-OFP with RE22Sm-GFP. 
A) Growth of sessile P. gallaeciensis and V. tubiashii (RE22Sm) in a co-culture 
system. B) Growth of planktonic P. gallaeciensis and V. tubiashii (RE22Sm) in a 
co-culture system. The data presented are average of two independent experiments 
and each independent experiment has three replicates. 
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Figure 6. Effect of pre-incubation of larval oysters with P. gallaeciensis strains at 
104 CFU/ml on survival (%± SE) 24 h after challenge with bacterial pathogen 
Vibrio tubiashii RE22 at 105 CFU/ml. The P. gallaeciensis strains were introduced 
24 h before larvae were challenged. Oyster larvae treated only by artificial 
seawater serve as control (mock). Bars marked with an asterisk (*) show 
significant differences (p<0.05). Representative of at least 3 experiments. 
 110 
 
 111 
Supplemental Data 
 
Table S1. Generation time of Phaeobacter gallaeciensis (S4Sm), Vibrio 
anguillarum (NB10Sm), and Vibrio tubiashii (RE22Sm) strains growing in YP30 
during mid-log phase. 
Strains S4Sm NB10Sm RE22Sm 
Generation Time (h) 3.098 0.892 0.528 
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Table S2. Competition assay between Phaeobacter strains and V. tubiashii 
(RE22Sm) with pre-colonization of Phaeobacter. The mixed culture are S4Sm 
with RE22Sm, clpX mutant with RE22Sm, clpX complement strain with RE22Sm, 
exoP mutant with RE22Sm, and exoP complement strain with RE22Sm. A) 
Growth of planktonic V. tubiashii (RE22Sm) in co-culture system. B) Growth of 
sessile V. tubiashii (RE22Sm) in co-culture system. The data presented are average 
of two independent experiments and each independent experiment has three 
replicates. aStatistically significant difference compared to RE22 only. 
 
RE22 cell density in liquid 
RE22 
only 
RE22 
w/S4sm 
RE22 
w/clpX- 
RE22 
w/exoP- 
RE22 
w/clpX-C 
RE22 
w/exoP-C 
100%  5.7%  93.1%  27.4%  6.8%  6.3%  
 
RE22 cell density on coverslip 
RE22 
only 
RE22 
w/S4sm 
RE22 
w/clpX- 
RE22 
w/exoP- 
RE22 
w/clpX-C 
RE22 
w/exoP-C 
100%  4.4%  86.5%  6.9%  3.6%  5.7%  
 
 
A 
B 
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Figure S1. A) Reversed-phase HPLC chromatograms of ethyl acetate extracts from 
Phaeobacter mutant strains. B) Quantification of biofilm formation by measuring 
OD580 of crystal violet dye attached to the cells forming biofilms on glass tubes at 
27C under static condition. The data presented are average of two independent 
experiments and each independent experiment has three replicates. 
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B 
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Figure S2. Competition assay between Phaeobacter strains and V. anguillarum 
(NB10Sm) without pre-colonization of Phaeobacter. The mixed cultures are 
S4Sm-OFP with NB10Sm-GFP, clpX-OFP with NB10Sm-GFP and exoP-OFP with 
NB10Sm-GFP. A) Single channel and merged confocal microscopy images of 
mixed biofilm development by OFP-producing strains (S4Sm, clpX mutant 
orexoPmutant) and GFP-producing V. anguillarum NB10Sm-GFP on the surface of 
glass coverslip at 48 h. The data presented is from a representative experiment of 
two independent experiments. B) Growth of sessileV. anguillarum (NB10Sm) in 
co-culture system with different Phaeobacter strains. C) Comparison of growth of 
sessile V. anguillarum (NB10Sm) in different co-culture system and monoculture 
control. D) Growth of planktonic V. anguillarum (NB10Sm) in co-culture system 
with different Phaeobacter strains. E) Comparison of growth of planktonic V. 
anguillarum (NB10Sm) in different co-culturesystemand monoculture control.The 
data presented are average of two independent experiments and each independent 
experiment has three replicates. 
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Figure S3. Effects of V. anguillarum NB10 on the growth of P. gallaeciensis strains 
in a competition assay with a 24 h without pre-colonization by P. gallaeciensis. 
The mixed cultures are: S4Sm-OFP with NB10Sm-GFP, clpX-OFP with 
NB10Sm-GFP and exoP-OFP with NB10Sm-GFP. Colonization and initial cell 
densities were as described in the Materials and Methods. A) Growth of sessile P. 
gallaeciensis cells (with NB10Sm) in a co-culture system and a monoculture 
control. B) Growth of planktonic P. gallaeciensis cells (with NB10Sm) in a 
co-culture system and a monoculture control. The data presented are average of 
two independent experiments and each independent experiment has three 
replicates. 
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Abstract 
Phaeobacter gallaeciensis S4Sm acts as a probiotic bacterium against the oyster 
pathogen, Vibrio tubiashii. S4Sm is an excellent biofilm former and produces the 
antibiotic tropodithietic acid (TDA). These two factors play important roles in 
probiotic activity. Here we report that culture supernatant of S4Sm down-regulates 
protease activity in V. tubiashii cultures. The effects of S4Sm culture supernatant 
on the transcription of several genes involved in protease activity 
including vtpA, vtpB, and vtpR (encoding metalloproteases A and B and their 
transcriptional regulator, respectively) were examined by qRT-PCR. Expression 
of vtpB and vtpR were reduced to 35.9 % and 6.6 %, respectively, compared to an 
untreated control. In contrast, expression of vtpA was not affected. We constructed 
a V. tubiashii GFP-reporter strain to detect the activity of inhibitory compounds. 
Using a bioassay-guided approach, the molecules responsible for V. 
tubiashii protease inhibition activity were isolated from S4Sm supernatant and 
identified as three N-acyl homoserine lactones (AHLs). The three AHLs are 
N-(3-hydroxydecanoyl)-L-homoserine lactone, 
N-(dodecanoyl-2,5-diene)-L-homoserine lactone and 
N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone, and their half maximal 
(50%) inhibitory concentrations (IC) against V. tubiashii protease activity are 
0.264 μM, 3.713 μM and 2.882 μM, respectively. Our qRT-PCR data 
demonstrated that exposure to the individual AHLs reduced transcription of vtpR 
and vtpB. Combinations of the three AHLs (any two AHLs or all three AHLs) 
on V. tubiashii showed additive effects among upon protease inhibition activity. 
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These AHL compounds may act by disrupting the quorum-sensing pathway that 
activates protease transcription of V. tubiashii. 
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Introduction 
Infections caused by pathogenic marine bacteria are a major problem for both 
the shellfish and finfish aquaculture industries, causing severe disease and high 
mortality, which seriously affect aquaculture production and cause significant 
economic loss [1, 2]. Opportunistic pathogens from the Vibrionaceae frequently 
cause disease in a variety of shellfish [3, 4]. For example, Vibrio tubiashii, a 
reemerging pathogen of larval bivalve mollusks, that causes invasive and toxigenic 
disease, has been responsible for high mortalities among oysters on the west coast 
of the United States [4]. The vibriosis is characterized by a rapid and large 
reduction in larval motility, detached vela, and necrotic soft tissue, which result in 
high mortality within one day of infection [5].  
While V. tubiashii virulence almost certainly involves several factors, the 
hemolysin and extracellular protease activities are thought to play important roles 
during pathogenesis in oysters [4, 6]. V. tubiashii RE22 encodes two 
metalloproteases, VtpA and VtpB [4] and at least one hemolysin locus [6]. The 
hemolysin locus contains two genes, vthA and vthB; vthA encodes a hemolysin, 
while vthB is thought to encode a chaperone for the VthA protein [6]. The 
extracellular metalloproteases facilitate bacterial invasion and the infection process, 
acting to enhance vascular permeability, leading to necrotic tissue damage and 
cytotoxicity in the host [7]. Mutations in the two protease genes resulted in 
significantly reduced protease activity of RE22 supernatant and toxicity to oyster 
larvae, thus these two proteases are considered as major virulence factors in V. 
tubiashii [4]. Although the regulation of the virulence factors in RE22 is not fully 
understood, Hasegawa et al. [8] reported that VtpR was a member of the TetR 
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family of transcriptional regulators and positively regulates several virulence 
factors, including VtpA, VtpB and VthBA in V. tubiashii RE22. VtpR was also 
found to exhibit high homology to several quorum sensing regulators, including 
LuxR (V. harveyi, 84%) and HapR (V. cholerae, 75%), suggesting that VtpR 
functions as quorum sensing regulator in V. tubiashii RE22. However, the 
mechanism(s) of VtpR regulation of various virulence factors in RE22 has not 
been fully investigated. 
Phaeobacter gallaeciensis is a gram-negative -Proteobacteria of the 
Roseobacter clade [9-11]. Previously, we isolated P. gallaeciensis S4 from inner 
surface of an oyster shell and showed that S4Sm (a spontaneous 
streptomycin-resistant mutant) could function as a probiotic treatment for oyster 
larvae. S4Sm exhibited strong anti-pathogen activity and increased host survival 
against V. tubiashii RE22 and Roseovarius crassostreae challenge [12]. We also 
demonstrated that tropodithietic acid (TDA) production, a broad spectrum 
antibiotic active against many marine pathogens, and biofilm formation play 
important roles in S4Sm probiotic activity [13]. However, the complete 
mechanisms for the probiotic activities of P. gallaeciensis S4Sm are still not fully 
understood.  
Besides antibiotic production, probiotic bacteria are able to secrete various 
types of secondary metabolites, some of which are used to antagonize pathogenic 
bacteria. Holmstrøm et al. [14] reported that Pseudomonas fluorescens AH2 strain 
secreted siderophores into the culture supernatant, which efficiently chelate iron, 
resulting in the cessation of growth due to iron deprivation for the pathogen Vibrio 
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anguillarum. Li et al. [15] reported that Lactobacillus reuteri produced cyclic 
dipeptides, which were able to quench agr-mediated expression of toxic shock 
syndrome toxin-1 in staphylococci. Bayoumi et al. [16] discovered that bioactive 
molecules produced by Bifidobacterium bifidum showed inhibitory activity against 
regulatory and virulence genes in the major pathogenicity islands of Salmonella 
typhimurium and E. coli O157:H7. 
In this report, we investigate the ability of P. gallaeciensis S4Sm to produce 
secondary metabolites inhibiting RE22 protease activity. The compounds were 
identified as N-acyl homoserine lactones (AHLs) by UHPLC, mass spectroscopy, 
and NMR. The active AHLs function to suppress the transcription of vtpR, the 
quorum sensing regulator that positively regulates protease (VtpB) production. 
These results contribute to a better understanding of interspecies cell-to-cell 
communication between P. gallaeciensis and V. tubiashii, and provide an 
additional mechanism by which probiotic bacteria may attenuate virulence factor 
production by bacterial pathogens.  
Materials and Methods 
Bacterial strains and growth conditions 
All bacterial strains and plasmids used in this study are listed in Table 1. S4 
was isolated from the inner surface of an oyster shell [12]. P. gallaeciensis strains 
and V. tubiashii strains were routinely grown in yeast extract (0.5%)-peptone 
(0.1%) broth plus 3% sea salts (YP30) [12], supplemented with the appropriate 
antibiotic, in a shaking water bath at 27°C. Overnight cultures of P. gallaeciensis 
or V. tubiashii, grown in YP30, were harvested by centrifugation (8,000 × g, 2 min) 
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and the pelleted cells were washed twice with nine-salt solution (NSS) [17]. 
Washed cells were resuspended to appropriate cell densities in experimental media. 
Cell densities were estimated by optical density at 600 nm (OD600) and more 
accurately determined by serial dilution and spot plating. Specific conditions for 
each experiment are described in the text. Escherichia coli strains were routinely 
grown in Luria-Bertani broth plus 1% NaCl (LB10) [18]. Antibiotics were used at 
the following concentrations: streptomycin, 200 μg/ml (Sm200) for P. gallaeciensis 
and Vibrio strains; ampicillin, 100 μg/ml (Ap100) for E. coli and Vibrio strains; 
chloramphenicol, 20 μg/ml (Cm20) for E. coli and 5 μg/ml (Cm5) for P. 
gallaeciensis and Vibrio strains; kanamycin, 50 μg/ml (Km50) for E. coli and 
Vibrio strains; and tetracycline, 15 μg/ml (Tc15) for E. coli. 
P. gallaeciensis supernatant challenge assay. 
The P. gallaeciensis supernatant challenge assay was a modification of the 
method described previously by Holmstrom and Gram [14]. P. gallaeciensis strain 
S4Sm was grown in YP30 at 27°C with shaking to stationary phase (20-24 h). The 
supernatant was collected by centrifugation at 8,000×g for 5 min, ﬁltered through a 
0.22-μm-pore-size cellulose-acetate ﬁlter, and used immediately. S4Sm 
supernatant challenge experiments were initially conducted by using exponentially 
growing V. tubiashii cultures (OD600 = 0.6 to 0.8) and transferring 1 ml of a culture 
to 4 ml of YP30 medium containing 2.5 ml of S4Sm supernatant and 1.5 ml of 
fresh YP30. For the control, 1 ml of an exponentially growing V. tubiashii culture 
was added to 4 ml of fresh YP30. Cell densities (CFU/ml) were determined at 
different times after challenge, also 1 ml V. tubiashii RE22 supernatant and mRNA 
were collected at each time point, and stored at -20°C and -74°C for future use, 
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respectively. All experiments were repeated at least twice. 
Detection and quantiﬁcation of protease activity 
The protease activity of culture supernatants was quantiﬁed using the 
azocasein method of Windle and Kelleher [19], as modiﬁed by Denkin and Nelson 
[20]. Culture supernatant was incubated with azocasein (6 mg/ml), which 
previously was dissolved in Tris-HCl (50 mM [pH 8.0]) containing 0.04% sodium 
azide (NaN3). Culture supernatant was prepared by centrifuging 1 ml of cells 
(12,000rpm, 10 min). Supernatant was removed and ﬁltered through a 
0.22-μm-pore-size cellulose-acetate ﬁlter. Filtered supernatant (100 μl) was 
incubated for 30 min at 27°C with 100 μl of azocasein solution. Reactions were 
terminated by the addition of trichloroacetic acid (TCA) (10% [wt/vol]) to a ﬁnal 
concentration of 6.7% (wt/vol). The mixture was allowed to stand for 2 min and 
centrifuged (12,000g, 8 min) to remove unreacted azocasein, and supernatant 
containing azopeptides was suspended in 700 μl of 525 mM NaOH. The 
absorbance of the azopeptide supernatant was measured at 442 nm. Protease 
activity units (U) were calculated with the following equation: U = [1,000 
(OD442)/CFU] × 10
9, where OD442 is the optical density at 442 nm.  
mRNA extraction 
mRNA extraction was performed using the protocol previously described by 
Mou and Nelson [21]. Exponential-phase cells (5 × 107 CFU/ml) and 
stationary-phase cells (2 × 109 CFU/ml) of V. tubiashii under different treatments 
were treated with RNA protect bacterial reagent (Qiagen, Valencia, CA) following 
the manufacturer's instructions. Total RNA was isolated using an RNeasy kit and 
QIAcube (Qiagen) following the manufacturer's instructions. All purified RNA 
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samples were quantified spectrophotometrically by measuring absorption at 260 
nm and 280 nm, using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific, Pittsburgh, PA), and were stored at −74°C for future use. 
Real-time quantitative RT-PCR. 
Real-time quantitative RT-PCR was performed using the protocol previously 
described by Li and Nelson [22]. Quantitative reverse transcriptase PCR 
(qRT-PCR) was used to quantify various mRNAs by use of a Roche480 multiplex 
quantitative PCR system and Brilliant II SYBR green single-step qRT-PCR master 
mix (Agilent Technologies, Wilmington, DE) with 10 ng of total RNA in 20 μl 
reaction mixtures. The thermal profile was 50 °C for 30 min, 95 °C for 15 min, and 
then 40 cycles of 95 °C for 30 s and 55 °C for 30 s. Fluorescence was measured at 
the end of the 55 °C step during every cycle. Samples were run in triplicate along 
with no-RT and no-template controls. All experiments were repeated at least twice. 
Ethyl acetate extraction of P. gallaeciensis S4Sm strain supernatant 
P. gallaeciensis supernatant was collected and partitioned by ethyl acetate 
(volume ratio, 1:1) twice. Ethyl acetate was allowed to evaporate via rotary 
evaporator and ethyl acetate crude extract was obtained and stored.  
Challenge of V. tubiashii cells with ethyl acetate extract of S4Sm supernatant 
Ethyl acetate crude extract from S4Sm supernatant was obtained by using the 
protocol described above and re-dissolved into fresh YP30 medium. In this 
experiment instead of using S4Sm supernatant, ethyl acetate extract of S4Sm 
supernatant was used to challenge V. tubiashii RE22 cells. CFU/ml of RE22 cells 
were determined at different time points after challenge (1, 2 and 3 hours), also V. 
tubiashii RE22 supernatant was collected at each time point, and stored at -20 °C 
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for future use, respectively.  
Construction of reporter strain V. tubiashii WZ112  
V. tubiashii RE22 was tagged by pSUP203P/PvtpB-gfp. Kanamycin resistant 
gene (kan) was amplified by PCR using the appropriate primer pair (Table 2) 
designed according to the sequence of pCR2.1-TOPO (Invitrogen, Carlsbad, CA). 
The PCR product was digested with HindIII and BamHI restriction enzymes and 
the DNA fragments separated on a 1% agarose gel. Subsequently, the gel-purified 
kan PCR fragment was ligated into pSUP202P-PflaB-gfp [13] after digestion with 
HindIII and BamHI and the ligation mixture was introduced into E. coli Sm10 (λ 
pir) by electroporation with Bio-Rad Gene Pulser II. Transformants were selected 
on LB10-Kan50 agar plates. The resulting plasmid was designated as 
pSUP203P-PflaB-gfp. The promoter region of vtpB gene was amplified by PCR 
using the appropriate primer pair (Table 2) designed according to the sequence of 
vtpB gene (accession no. GQ121132). The PCR product was digested with KpnI 
restriction enzyme and the DNA fragments separated on a 1% agarose gel. The 
gel-purified PvtpB PCR fragment was further digested by alkaline phosphatase 
(Promega, Madison, WI). Subsequently, the kit-purified PvtpB PCR fragment was 
ligated into pSUP203P-PflaB-gfp [13] after digestion with KpnI, and the ligation 
mixture was introduced into E. coli Sm10 (λ pir) by electroporation with Bio-Rad 
Gene Pulser II. Transformants were selected on LB10-Kan50 agar plates. The 
resulting plasmid was designated as pSUP203P-PvtpB-gfp. The resulting clones 
were sequenced at the University of Rhode Island Genomics and Sequencing 
Center. Only pSUP203P-PvtpB-gfp with the correct orientation of PvtpB was 
transferred from E. coli Sm10 into RE22Sm by conjugation using the procedures 
described previously [21]. The transconjugants were confirmed by antibiotic 
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selection and fluorescence microscopy. 
Protease inhibitory activity guided extraction and isolation of ethyl acetate 
extract of P. gallaeciensis S4Sm 
The ethyl acetate extract of P. gallaeciensis S4Sm was separated using a 
Sephadex LH-20 column (3  80 cm) and eluted with chloroform-methanol (1:1, 
v/v) to give 60 fractions. Aliquotes were transferred into a 96-well plate and dried. 
Reporter strainV. tubiashii WZ112 culture (200 μl, OD600 = 0.3) was added into 
each well containing the dried ethyl acetate extract fractions. After 1.5 h incubation 
at 27°C, the OD600 and fluorescence signals in each well were measured (Mx3005 
multiplex quantitative PCR system, plate read function) and the relative 
fluorescence (RF, fluorescence unit/OD600) of each well was calculated. Wells with 
lower RF values than the negative controls were considered to contain potential 
quorum quenching activity and were saved for further analysis. After the first 
round of screening, fractions 13 to 27 (of 60 fractions) had lower RFU and were 
pooled to yield Fraction A for further analysis. Fraction A (123.2 mg) was 
separated by medium pressure liquid chromatography (MPLC) and eluted with 
gradient methanol-water (from 10:90 to 100:0, v/v, 3 mL/min) to give 29 fractions. 
Fractions 21 to 29 had lower RF activity than the negative controls and were 
combined into Fraction B for further purification. Fraction B (48.5 mg) was 
purified by the semi-preparative high performance liquid chromatography (HPLC) 
and eluted with methanol-water (0-25 min: from 40:100 to 100:0; 25-30 min: 
100:0; v/v, 3 ml/min) to give active compounds DR-8 (2.0 mg), DR-11 (600 g), 
and DR-12 (500 g) (Fig. 4).  
Concentration–Response Analyses of three AHL compounds 
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Exponentially growing V. tubiashii cultures (OD600 = 0.6 to 0.8) were treated 
with a series of dilutions of the purified AHL molecules from P. gallaeciensis. 1 
volume of V. tubiashii culture was added to 4 volumes of fresh YP30 medium 
containing a specific concentration of AHL (dissolved in methanol, 0.4% final 
concentration). Additions containing only methanol (0.4%, final concentration) 
were used as controls. V. tubiashii RE22 supernatant were collected at 1.5 h, and 
used for examining the protease activity. A series of concentration-response data 
(drug concentrations x1, x2... xn and relative protease activities y1, y2 ...yn) were 
obtained and then plotted. According to the concentration-response curve half 
maximal inhibitory concentrations (IC50) were calculated for each purified AHL.  
Treatment of V. tubiashii cells with purified AHLs 
Exponentially growing V. tubiashii cultures (OD600 = 0.6 to 0.8) were treated 
with AHL molecules at the IC50 individually and in combinations of two or three 
AHL molecules. Briefly, 1 volume of V. tubiashii culture was added to 4 volumes 
of fresh YP30 medium containing the appropriate concentration of AHL(s) 
dissolved in methanol (0.4%, final concentration). Additions containing only 
methanol (0.4%, final concentration) were used as controls. Cell densities (CFU/ml) 
were determined at 15 min and 90 min after addition of AHL(s), also V. tubiashii 
RE22 culture supernatant and mRNA were collected at each time point, and stored 
at -20°C and -74°C for future analysis, respectively.  
Statistical analysis 
Two-tailed Student's t tests assuming unequal variances were used for 
statistical analyses for all experiments. P values of <0.05 were considered 
statistically significant. 
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Results 
Supernatant of P. gallaeciensis S4Sm inhibited protease activity of RE22, but 
not growth 
Prior work with P. gallaeciensis S4Sm showed that tropodithietic acid (TDA) 
production and biofilm formation play very important roles in probiotic activity of 
S4Sm against the marine pathogens, V. tubiashii and V. anguillarum [13]. In an 
effort to more completely understand the probiotic activity of P. gallaeciensis 
S4Sm, we investigated the effects of S4Sm culture supernatant against V. tubiashii 
protease activity, a major virulence factor. When a V. tubiashii culture (~1×108 
CFU/ml) was incubated in fresh YP30 containing an equal volume of 
sterile-filtered culture supernatant from a stationary phase P. gallaeciensis culture 
(grown to ~2×109 CFU/ml) the protease activity of RE22Sm was suppressed in 
response to growth with S4Sm supernatant (Fig. 1A). More specifically, at 1 h no 
protease activity was detected in the sample incubated with S4Sm supernatant, 
while the control culture had 149 ± 33 U of protease activity. At later times 
protease activity from the S4Sm-treated sample increased, but was still 
significantly lower than that of control. In contrast, the growth of V. tubiashii 
RE22Sm in YP30 (control) and in YP30 supplemented with S4Sm supernatant was 
nearly identical (Fig. 1B).  
Supernatant of P. gallaeciensis S4Sm inhibited transcription of vtpB and vtpR, 
but not vtpA 
Previous studies with V. tubiashii indicated that VtpR, a member of the TetR 
family of transcriptional regulators and a homolog of HapR and LuxR, functioned 
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as a global regulator controlling an array of potential virulence factors, including 
the two metalloproteases VtpA and VtpB [8]. VtpA and VtpB have been 
demonstrated to be major virulence factors and responsible for the protease activity 
of V. tubiashii RE22Sm [4]. Since S4Sm culture supernatant inhibited induction of 
RE22Sm protease activity, we first examined whether there is a protease inhibitor 
in S4Sm culture supernatant, which could inhibit RE22Sm protease activity. Equal 
volumes of a RE22Sm culture supernatant with protease activity were mixed with 
either sterile YP30 medium or with sterile filtered S4Sm culture supernatant 
(grown in YP30) and the relative protease activity was determined (Fig. S1). 
Sterile YP30 and sterile filtered S4Sm culture supernatant served as controls. Our 
data demonstrated that a S4Sm culture supernatant did not directly inhibit RE22Sm 
protease activity. The mixture of S4Sm and RE22Sm cell-free culture supernatants 
(1:1 mixture) had the same protease activity as the mixture of fresh YP30 medium 
and RE22Sm supernatant (1:1 mixture) (Fig. S1), indicating that there was no 
direct protease inhibitor in the S4Sm supernatant. Next, we examined, using 
real-time qRT-PCR, whether this inhibition resulted from inhibition of 
transcription of the vtpA, vtpB and vtpR genes. RE22Sm cells grown in YP30 to 
late exponential phase (~108 CFU/ml) were treated with sterile-filtered S4Sm 
culture supernatant (1:1 mixture) and samples were collected after 15 min and 60 
min of incubation for determination of vtpA, vtpB, and vtpR transcription (Fig. 2). 
Transcription from both vtpB and vtpR was reduced in the RE22 cultures treated 
with the S4Sm culture supernatant when compared to the control cultures (Fig. 
2A&B). Specifically, transcription of vtpB and vtpR in the S4Sm 
supernatant-treated sample were 35.9% and 6.6%, respectively, of the control. 
After 60 min of incubation in S4Sm supernatant, transcription of vtpB and vtpR 
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was 41% and 29%, respectively, of the control. In contrast, there appeared to be no 
significant difference between the transcription of vtpA in RE22 cultures treated 
with S4Sm culture supernatant and the control (Fig. 2C). After 15 min of 
incubation the treated culture showed 136% transcription of vtpA compared to the 
control, while at 60 min transcription of vtpA in the treated culture was 89% of the 
control. Additionally, the amount of vtpA transcription was two to three orders of 
magnitude lower than transcription of vtpB in the control sample. The data 
presented here suggest that one or more compounds found in the S4Sm culture 
supernatant inhibited RE22Sm protease activity by suppressing transcription from 
the vtpR transcriptional regulator; this would decrease vtpB transcription and 
decrease protease activity. Further, our data suggest that VtpB, not VtpA, is the 
major metalloprotease when RE22 in late exponential phase (Fig. 2C).  
Ethyl acetate extract of S4Sm supernatant inhibited protease activity of 
RE22Sm 
We confirmed that TDA (0.5-1.0 μg/ml) did not inhibit protease activity, but 
did inhibit RE22 growth when cells (2×108 CFU/ml) were grown in YP30 (27 °C) 
for 1 h (Fig. S2). This observation strongly suggested that molecules other than 
TDA secreted by S4Sm were responsible for the inhibition of protease 
transcription and activity. In order to narrow down the possible molecules, we 
tested an ethyl acetate extract of S4Sm supernatants. The ethyl acetate and aqueous 
soluble fractions were added to RE22Sm cells to determine their effects on 
protease activity and growth (Fig. 3). Although growth of V. tubiashii RE22Sm in 
YP30 medium (control), YP30 supplemented with S4Sm supernatant, YP30 
supplemented with ethyl acetate extract of S4Sm supernatant or YP30 
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supplemented with aqueous layer extract of S4Sm supernatant were similar (Fig. 
3A), the protease activity of RE22Sm was dramatically reduced in response to 
exposure to S4Sm supernatant or the ethyl acetate extract of S4Sm supernatant 
(Fig. 3B). These results suggested that the compounds that inhibit RE22Sm 
protease expression were in the ethyl acetate extract and are likely non-polar 
molecules. 
Screening for active compounds  
In order to guide the isolation of the active compounds, a reporter strain, V. 
tubiashii WZ112, was constructed (Table 1). WZ112 harbors a plasmid, which 
containing the promoter region of vtpB fused to a promoterless gfp. WZ112 was 
cultivated in 96-well plates in the presence of YP30 supplemented with 
HPLC-derived fractions of ethyl acetate extract of S4Sm culture supernatant. Wells 
with fractions containing the active compounds had lower fluorescence signals 
(Fig. 4). Three rounds of screening resulted in the isolatation of three active 
compounds, designated DR-8, DR-11 and DR-12 (Fig. 5).  
Identification of the structures of the active compounds 
Bioassay guided isolation of the ethyl acetate extract of P. gallaeciensis S4 
(Fig. 4) resulted in isolating three compounds (DR-8, DR-11, and DR-12) with 
potent protease inhibitory activities. Their chemical structures were elucidated by 
the extensive analysis of NMR and MS spectra. All three compounds were 
identified as N-acyl-homoserine lactones (AHLs) (Fig. 5).  
The mass spectrum of compound DR-8 showed pseudomolecular ions at m/z 
[M+H]+ and [M+Na]+, and its 1H and 13C NMR data were identical to those of 
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previously reported AHL compound (3R)-N-(3-hydroxydecanoyl)-L-homoserine 
lactone. The molecular formula of compound DR-11 was determined as 
C16H25NO3 by HRESIMS at m/z 302.1729 [M+Na]
+ (calcd for C16H25NO3Na, 
302.1732). Compound DR-11showed the similar 1H and 13C NMR data with 
compound DR-8, the difference between them resided in the side chain. Four 
olefinic protons signal at δ6.80 (1H, dt, J = 15.6, 6.3 Hz, H-3), 5.95 (1H, dt, J = 
15.6, 1.7 Hz, H-2), 5.55 (1H, m, H-6) and 5.41 (1H, m, H-5), were observed in the 
1H NMR spectrum, which indicated the presence of two double bonds in the side 
chain. Analysis of 2D NMR (1H-1H COSY and HMBC) data allowed the 
assignment of the position of double bonds. The 2E, 5Z configurations were 
determined by the coupling constant (J2,3 = 15.6 Hz) and the NOESY correlation 
between H-5 and H-6. Thus, the compound DR-11 was elucidated as (2E, 
5Z)-N-(dodecanoyl-2,5-diene)-L-homoserine lactone, which is a new compound. 
Compound DR-12 was identified as (3R, 
7Z)-N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone by the comparison 
NMR data with those of previously reported data [32] (Fig. 5). 
Concentration–response analyses of the three AHLs 
A series of different concentrations of each AHL were used to treat late 
exponential phase V. tubiashii RE22Sm and the protease activities were measured. 
All three AHLs showed inhibition effects on the protease activity produced by 
RE22Sm, without effects on V. tubiashii growth (Fig. S3). Inhibition activities of 
the three AHLs are concentration-dependent (Fig. 6). According to 
concentration-response curve, the half maximal (50%) inhibitory concentration 
(IC50) of DR-8, DR-11, and DR-12 were determined to be 0.264 μM, 3.713 μM 
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and 2.882 μM, respectively. 3OHC10-HSL was the most potent inhibitor of 
RE22Sm protease activity when compared to the other two AHL molecules. Since 
the AHLs were dissolved in methanol (0.4%, final concentration), we also treated 
RE22 cells with methanol only as a control. This treatment did not inhibit RE22 
protease activity (data not shown).  
Exposure to the individual AHL (IC50) reduced transcription of vtpR and 
vtpB, but not vtpA 
Since the IC50 values for the individual AHLs were based on protease 
activity (Table 3), we were interested in determining whether transcription of the 
individual genes involved with V. tubiashii RE22 protease activity was similarly 
affected. Cultures of RE22 were grown to late exponential phase (~108 CFU/ml) 
and exposed to the three individual S4Sm-derived AHLs at their IC50. After 15 
min, cells were harvested, extracted for total RNA, and the amount of mRNA 
copies for vtpA, vtpB, and vtpR was determined by real time qRT-PCR. The data 
presented in Fig. 7 demonstrate that transcription of vtpB, was reduced to ~42-51% 
of the untreated control, and transcription of vtpR was reduced to 13.6-14.7% of 
the untreated control. In contrast, transcription of vtpA was not affected by 
treatment with the purified AHLs. Transcription of vtpA in the treated samples was 
98-110% of the untreated control. Further, transcription of vtpA was about two to 
three orders of magnitude lower than vtpB (8.9 ×103 vs. 7.3 ×106). These data 
demonstrate that the three AHLs produced by P. gallaeciensis S4Sm inhibit the 
transcription of the transcriptional regulator, VtpR, to down-regulate transcription 
of the metalloprotease VtpB.     
Effects of the three AHLs upon protease inhibition activity were additive 
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In order to obtain more information about the mechanism by which vtpR and 
vtpB transcription is inhibited, we used different combinations of any two or three 
AHLs to treat RE22Sm cells to determine whether their effects were additive. The 
concentration of each AHL was set at its calculated IC50 (see above). Single AHL 
treatment by 3OHC10-HSL, C12:2-HSL and 3-OHC14:1-HSL suppressed 
RE22Sm protease activity to ~50% of the untreated control (Fig.8). Treatment of 
RE22 cells with a combination of any two AHLs (each at IC50) decreased protease 
activities further: 32.4% for DR8 + DR11, 26.9% for DR8 + DR12 and 34.1% for 
DR11 + DR12 (Fig. 8). Treatment of RE22 cells with all three AHLs (each at IC50) 
resulted in the greatest inhibition of protease activity with the treated cells having 
only 18.0% of the control cell activity (Fig. 8).  
Discussion 
P. gallaeciensis has been shown to exhibit probiotic activity that protects fish 
species such as turbot and cod against the bacterial pathogen, V. anguillarum [23, 
24]. D’Alvise et al [24] demonstrated that TDA production by P. gallaeciensis 
plays a key role in probiotic activity. Recently, our group successfully isolated P. 
gallaeciensis S4 from inner shell of a healthy Eastern oyster (Crassostrea 
virginica), and showed that this isolate has probiotic activity and is able to protect 
oyster larvae from challenge with two oyster pathogens, V. tubiashii and R. 
crassostreae [12]. We also demonstrated that P. gallaeciensis S4 probiotic activity 
not only relies upon TDA production, but also biofilm formation [13]. 
In this study, we present data that in addition to TDA, S4 produces secondary 
metabolites, identified as AHLs, which have specific anti-virulence activity and 
may contribute to P. gallaeciensis probiotic activity against the marine pathogen, V. 
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tubiashii, in oyster larvae.  Specifically, we found that stationary phase culture 
supernatant of P. gallaeciensis S4 had the ability to repress protease activity, but 
not the growth of V. tubiashii RE22 (Fig. 1). The repression of protease activity 
was specifically due to the repression of the protease gene vtpB and its 
transcriptional activator vtpR (Fig. 2) [8]. A vtpB-gfp reporter strain of V. tubiashii 
was constructed and used to screen the ethyl acetate-soluble fractions of the culture 
supernatant of stationary phase P. gallaeciensis S4 cells (Fig. 3) and the successive 
fractionations by liquid chromatography to isolate three compounds of interest (Fig. 
4). The three compounds were found to be AHLs by a combination of NMR and 
mass spectroscopy analysis (Fig. 5) and identified as 
N-(3-hydroxydecanoyl)-L-homoserine lactone, 
N-(dodecanoyl-2,5-diene)-L-homoserine lactone and 
N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone. While each AHL is able 
to repress vtpR and vtpB, DR8 is the most active compound (lowest IC50 value), 
followed by DR12 and DR11, respectively (Figs. 6). Further, the effects of the 
AHLs are additive (Fig. 8). Since the isolated compounds are AHLs, this suggests 
that they function as QS compounds for P. gallaeciensis S4 and as quorum 
quenching (QQ) compounds against V. tubiashii RE22.  
Quorum sensing (QS) has been demonstrated to regulate diverse 
physiological activities in Gram-positive and Gram-negative bacteria including 
virulence, symbiosis, competence, conjugation, antibiotic production, motility, and 
biofilm formation [25]. Gram-negative bacteria generally use AHLs as 
autoinducers for QS. Quorum quenching (QQ), which is disruption of QS 
pathways by any of several mechanisms (including antagonist binding to the native 
AHL receptor, degradation native AHL signals or suppression of AHL synthetase 
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and receptor activities, stabilities and productions [26]) can affect QS-regulated 
bacterial physiological functions [27]. It has been shown that synthetic antagonists 
are able to block pathogenic bacterial quorum sensing in Pseudomonas aeruginosa 
and Agrobacterium tumefaciens [28, 29]. Some bacteria, like Bacillus and 
Streptomyces strains, are able to produce AHL-degrading enzymes, such as 
lactonase [30] and acylase [31]. The degraded AHL products by those enzymes are 
no longer active in quorum sensing. Thus, in pathogenic bacteria, whose virulence 
is AHL-mediated, QQ of QS-regulated virulence factors can control infection and 
disease caused by those bacteria. 
Our data suggests that AHLs from P. gallaeciensis S4 strain work as 
antagonists to the AHL receptor in V. tubiahsii (our proposed model showed in Fig. 
9). By using two AHL indicator strains, E. coli JB525, which detects C6- to 
C8-HSL; and E. coli JM109L, which detects C10- to C12-HSL [20], we found that 
V. tubiashii RE22 and P. gallaeciensis S4 secrete C10- to C12-HSL, but no C6- to 
C8-HSL. This suggested that since RE22 and S4 share the same range of AHLs, 
AHL molecules from one of them may act as antagonist to the other. The protease 
inhibition activity of S4 supernatant is transient, as it gradually diminished during 
the experiment (Fig. 1A & 3B). One possibility for this observation is competitive 
inhibition of RE22-AHL-mediated QS regulation of vtpR gene expression. 
Specifically, as V. tubiashii cells grow, increasing concentrations of native 
RE22-AHLs are produced, diluting the exogenous S4-AHLs, and resulting in 
decreased antagonizing effects from S4-AHL molecules towards RE22 protease 
activity. Studies on AHL production profile of V. tubiashii and comparison 
between S4 and RE22 AHLs, as well as AHL binding to AHL receptor proteins 
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need to be carried out in order to determine the QQ mechanism applied by P. 
gallaeciensis AHL molecules. 
Similarly, in Chromobacterium violacium, a Gram-negative bacterium 
commonly found in soil and water, longer chain AHLs (C10-C14-HSL) showed 
transient inhibition of purple pigment violacein production, which could be 
induced by HHL (C6-HSL), a shorter chain AHL [32]. The inhibition mechanism 
by longer chain AHLs towards shorter chain AHL has not been described, but it 
may also be an example of QQ by competitive inhibition.  
Previously, Berger et al [33] showed that P. gallaeciensis produces 
N-3-hydroxydecanoylhomoserine lactone, which is involved in the QS-induction 
of the TDA biosynthesis genes in P. gallaeciensis. Similarly, 
N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone is produced by 
Rhizobium leguminosarum, where it is regulates several QS-mediated pathways, 
including growth inhibition, adaptation to stationary phase, and shorter chain AHL 
production [34]. To our knowledge, the production of 
N-(dodecanoyl-2,5-diene)-L-homoserine lactone has not been previously reported 
and is a newly discovered AHL. No previous studies have described any biological 
functions of either N-(dodecanoyl-2,5-diene)-L-homoserine lactone or 
N-(3-hydroxytetradecanoyl-7-ene)-L-homoserine lactone in P. gallaeciensis. 
Generally, AHL molecules contain a common homoserine lactone moiety and 
a specific fatty acid side chain. The side chain varies within different species. 
Therefore, the specificity for AHL signals is conferred by the length and 
modifications to the acyl groups [26]. Basically, different AHL receptors only 
recognize specific AHL molecules. Our data suggest that the protease inhibition 
effect of S4 AHLs is species-specific. We found that expression of vanT, a 
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homolog of vtpR in V. anguillarum M93 strain [35], was not affected by addition 
of S4 supernatant into M93 cell culture (Fig. S4). This might be because regulation 
of vanT expression is different in V. anguillarum compared to regulation of vtpR 
expression in V. tubiashii. By using AHL indicators mentioned above, we found 
that V. anguillarum M93 secreted both C6-C8 and C10-C12 HSLs (Table. S1). 
Therefore, vanT expression (and protease activity) is not influenced by S4 AHLs 
because M93 and S4 use different ranges of AHLs for QS regulation.  
Interestingly, treatment of P. gallaeciensis S4 with RE22 culture supernatant 
did not affect the expression of RaiR, the quorum sensing regulator in S4 strain 
[33]. RaiR of S4 is a homolog of PgaR in P. gallaeciensis DSM17395, and their 
sequence share almost 96% identity at amino acid level. Cell-free culture 
supernatant of stationary phase V. tubiashii cells was collected and used to treat P. 
gallaeciensis cells during late exponential phase. Both the S4 growth rate and RaiR 
transcription were the same in the treated and control cultures (Fig. S5). This might 
be because that native S4-AHLs have a higher binding affinity for the S4 AHL 
receptors than do the exogenous RE22-AHLs.  
To our knowledge we describe here for the first time that a gram negative 
probiotic bacterium is able to not only efficiently colonize its host, and secrete an 
antibiotic, but also produce anti-virulence agents, AHLs, to cause QQ in a specific 
pathogen, which shares the same niche with the probiotic bacterium; as a result, the 
probiotic bacterium inhibits the growth of and kills the pathogen using antibiotics 
and it blocks expression of virulence factors in the pathogen, eventually benefiting 
the oyster host.  
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Table 1. Bacterial strains and plasmids used in this study. 
 
 
Strains or 
plasmids 
Description Resistance Reference 
P. 
gallaeciensis 
      
S4 
Previously named as 
Phaeobacter sp. S4; wild 
type isolate from the inner 
shell of oysters 
 
Karim et al, 
2013 
S4Sm 
Spontaneous Smr mutant of 
S4 
Smr Zhao et al, 2014 
V. tubiashii    
RE22Sm 
Spontaneous Smr mutant of 
RE22 
Smr Zhao et al, 2014 
WZ112 
Reporter strain, RE22Sm 
tagged by 
pSUP203P-PvtpB-gfp 
SmrKmr Apr this study 
V. 
anguillarum 
   
M93sm 
Spontaneous Smr mutant of 
M93 (serotype J-O-1) 
Smr 
Denkin et al, 
2004 
E. coli    
Sm10 
thi thr leu tonA lacY supE 
recA RP4-2 Tc::Mu::Km 
(λpir) 
Kmr 
Simon et al, 
1983 
WS203 Sm10(pSUP203P) CmrKmr Apr this study 
WS203-vtpB 
Sm10(pSUP203P-PvtpB-gfp
) 
Kmr Apr this study 
JB525 MT102(pJBA132) Tcr 
Andersen et al. 
2001 
JM109L JM109(pSB1075) Apr 
Winson et al. 
1998 
Plasmids    
pSUP202P-Pfl
aB-gfp 
AprTcr;   Zhao et al, 2014 
pSUP203P-Pvt
pB-gfp 
AprKmr; derivative from 
pSUP202P-PflaB-gfp 
 this study 
pJBA132 
luxR-PluxI-RBSII-gfp (ASV
) in pME6031 (detects C6- to 
C8-AHLs) 
 
Andersen et al. 
2001 
pSB1075 
luxCDABE fused to lasRI′ in 
pUC18 (detects C10- to 
C12-AHLs) 
  
Winson et al. 
1998 
 146 
 
Table 2. Primers used in this study 
Primer Sequence (5' to 3', underlined 
sequences are engineered 
restriction sites) 
Description 
pw200 
Kan202 F 
GCGGTAAAGCTTGAACACGTAGA
AAGCCAGTCC 
amplification of kan ORF, 
forward, with HindIII site 
pw201 
Kan202 R 
CTATATGGATCCCGTTTCTGGGTG
AGCAAAAAC 
amplification of kanORF, 
reverse, with BamHI site 
pw204 
PvtpB F 
GATGTTGGTACCTGTGGATCTCTG
CCATTGGCT 
amplification of vtpB promoter 
region, forward, with KpnI site 
pw205 
PvtpB R 
CTGCATGGTACCTATGATTCTCCT
TATCGTGGC 
amplification of vtpBpromotor 
region, reverse, with KpnI site 
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Figure 1. Effects of supernatant of P. gallaeciensis S4Sm upon protease activity and 
growth of V. tubiashii RE22Sm. A) Determination of protease activities of V. tubiashii 
RE22Sm strain treated with S4Sm supernatant or fresh YP30 medium (control) by 
measuring OD442 of azopeptide from azocasein degradation caused by protease 
activity. B) Growth of V. tubiashii RE22Sm cells treated with S4Sm supernatant or 
fresh YP30 medium (control). The data presented are average of two independent 
experiments and each independent experiment has three replicates.  
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Figure 2. Effects of a supernatant of stationary phase P. gallaeciensis S4Sm upon 
transcription of vtpA, vtpB and vtpR in V. tubiashii RE22Sm. Expression of vtpA, vtpB 
and vtpR determined by qRT-PCR analysis of V. tubiashii RE22Sm during late 
logarithmic phase growth under P. gallaeciensis supernatant treatment. The data 
presented are representative of two independent experiments. Each value is the 
average for three replicates.  
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Figure 3. Effects of different fractions of P. gallaeciensis S4Sm supernatant upon 
protease activity and growth of V. tubiashii RE22Sm. A) Determination of protease 
activities of V. tubiashii RE22Sm strain treated with S4Sm supernatant or fresh YP30 
medium (control) by measuring OD442 of azopeptide from azocasein degradation 
caused by protease activity. B) Growth of V. tubiashii RE22Sm cells treated with 
S4Sm supernatant or fresh YP30 medium (control). The data presented are average of 
two independent experiments and each independent experiment has three replicates 
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Figure 4. Schematic diagram of isolation process of three N-acyl homoserine lactones. 
In order to guide the isolation of the active compounds, a reporter strain, V. tubiashii 
WZ112, was constructed (Table 1). WZ112 harbors a plasmid, which contains the 
promoter region of vtpB fused to a promoterless gfp. WZ112 was cultivated in 96-well 
plates in the presence of YP30 supplemented with HPLC-derived fractions of ethyl 
acetate extract of S4Sm culture supernatant. Wells with fractions containing the active 
compounds had lower fluorescence signals.  
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Figure 5. Chemical structures of three N-acyl homoserine lactones. Chemical 
structures for the three active compounds with potent protease inhibition activity were 
elucidated by the extensive spectra analysis including NMR and MS spectrum. All 
three compounds were identified as N-acyl-homoserine lactones (AHLs). 
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Figure 6. Concentration–response analyses of the three AHLs. A series of different 
concentrations of each AHL were used to treat V. tubiashii RE22Sm and the protease 
activities were measured. Concentration-response curves (trendlines) of each AHL 
were obtained.  
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Figure 7. Effects of single AHL treatment upon transcription of vtpA, vtpB, and vtpR in 
V. tubiashii RE22Sm. Expression of vtpR, vtpB, and vtpA determined by qRT-PCR 
analysis of V. tubiashii RE22Sm treated by individual AHL (at their own IC50) during 
late logarithmic phase growth (~1-2×108 CFU/ml). The data presented are 
representative of two independent experiments. Each value is the average for three 
replicates. 
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Figure 8. Effects of different combinations of three AHLs upon protease activity of V. 
tubiashii RE22Sm. Determination of protease activities of V. tubiashii RE22Sm strain 
treated with single AHL, various combinations of AHLs or appropriate amount of 
methanol (control) by measuring OD442 of azopeptide from azocasein degradation 
caused by protease activity. The data presented are representative of two independent 
experiments. Each value is the average for three replicates. 
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Figure 9. Proposed model: inhibition mechanism of P. gallaeciensis AHLs. A) 
Proposed quorum sensing pathway of V. tubiashii cells at late exponential phase. B) 
Proposed quorum quenching on V. tubiashii cells at late exponential phase in response 
to P. gallaeciensis S4 AHL molecules. Green solid circle represents V. tubiashii native 
AHLs, red solid circle represents P. gallaeciensis AHLs. 
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Table S1. AHLs secreted by various bacterial strains detected using AHL indicator 
strains* 
 
AHL  Organism 
C6-C8-HSL C10-C12-HSL 
P. gallaeciensis S4Sm No Yes 
V. tubiashii RE22Sm No Yes 
V. anguillarum M93Sm Yes Yes 
 
*: AHL production measured with E. coli JB525 gfp-based (which responds to 
C6-C8-HSL) and E. coli JM109L lux-based (which responds to C10-C12-HSL) AHL 
sensor strains. Cell-free supernatant from S4Sm, RE22Sm and M93Sm growing in 
YP30 or LB20 were added to AHL indicator strains and fluorescence or luminescence 
signal, respectively, were measured by appropriate microtiter plate readers [20].    
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Figure S1. Direct protease inhibitor detection in P. gallaeciensis S4 supernatant. 
Determination of protease activities from different bacterial cell supernatant or 
supernatant mixtures by measuring OD442 of azopeptide from azocasein degradation 
caused by protease activity. The data presented are representative of two independent 
experiments. Each value is the average for three replicates. 
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Figure S2. Effects of TDA at different concentration (0.5 μg/ml or 1.0 μg/ml) upon 
protease activity and growth of V. tubiashii RE22Sm. A) Determination of protease 
activities of V. tubiashii RE22Sm strain treated with TDA or fresh YP30 medium 
(control) by measuring OD442 of azopeptide from azocasein degradation caused by 
protease activity. B) Growth of V. tubiashii RE22Sm cells treated with TDA or fresh 
YP30 medium (control).  
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Figure S3. Effects of P. gallaeciensis AHLs upon growth of V. tubiashii RE22Sm. A 
series of different concentrations of each AHL were used to treat V. tubiashii RE22Sm 
and cell density (OD600) was measured. The relative growth of RE22 compared to the 
control (methanol) was calculated.  
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Figure S4. Effects of supernatant of P. gallaeciensis S4Sm upon transcription of vanT 
in V. anguillarum M93Sm. Expression of vanT determined by qRT-PCR analysis of V. 
anguillarum M93Sm during late logarithmic phase growth under P. gallaeciensis 
supernatant treatment.  
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Figure S5. Effects of supernatant of V. tubiashii RE22Sm upon growth and 
transcription of raiR in P. gallaeciensis S4Sm. A) Growth of P. gallaeciensis S4Sm 
cells treated with RE22Sm supernatant or fresh YP30 medium (control). B) 
Expression of raiR determined by qRT-PCR analysis of P. gallaeciensis S4Sm during 
late logarithmic phase growth (~ 4×108 CFU/ml) under RE22Sm supernatant 
treatment. The data presented are average of two independent experiments and each 
independent experiment has three replicates.  
 
 
 
 
 
175 
 
 
 
176 
Appendix A (additional table for Manuscript I) 
Inhibition zone assay 
Probiotic Pathogens Strain 
Inhibition zone 
(mm) 
Roseovarius crassostreae CV919-312 12 
Vibrio harveyi BB120 17 
Vibrio harveyi DN01 7 
Vibrio tubiashii  RE22 7 
Vibrio anguillarum M93 13 
Phaeobacter 
gallaeciensis S4 
Vibrio anguillarum NB10 13 
 
Anti-bacterial activity of P. gallaeciensis strains was measured by a growth inhibition 
assay using V. anguillarum, V. tubiashii, and R. crassostreae as the target organisms. 
Briefly, an aliquot (100 μl) from a stationary phase overnight culture of the 
appropriate Vibrio or R. crassostreae culture was spread onto YP30 agar plates, then 
10 μl of a 2-day-old culture (OD600 = 0.8) of a P. gallaeciensis strain was spotted in 
triplicate onto the pathogen cell lawn. After incubation at 27°C for 24 h, the level of 
antibacterial activity was determined by the diameter of the inhibition zone around the 
P. gallaeciensis colonies 
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Appendix B (additional figures for Manuscript III) 
Figure 1. Map of V. tubiashii vtpB reporter plasmid 
 
 
 
 
 
V. tubiashii vtpB reporter plasmid 
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Figure 2. Proposed model to explain the observation that S4 AHLs at IC50 were not 
able to affect protease production of V. tubiashii stationary phase cells; however, S4 
AHLs at 2 × IC50 exhibited protease inhibition activity upon V. tubiashii stationary 
cells. 
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Figure 3. Effects of S4 AHLs at different concentrations upon protease production of 
V, tubiashii stationary phase cells. 
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Figure 4. Proposed model to explain the observation that S4 AHLs had no effects on 
protease production of V. anguillarum cells 
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